<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>OncologySTAT Journal Scans via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'OncologySTAT Journal Scans' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=OncologySTAT+Journal+Scans&t=OncologySTAT+Journal+Scans&s=Search&f=source]]></link>
        <lastBuildDate>Sun, 31 Jan 2010 13:50:23 +0100</lastBuildDate>
        <item>
            <title>Radiotherapy Plus Cetuximab for Locoregionally Advanced Head and Neck Cancer: 5-Year Survival Data From a Phase 3 Randomised Trial, and Relation Between Cetuximab-Induced Rash and Survival</title>
            <link>http://www.medworm.com/index.php?rid=3045816&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FRadiotherapy_Plus_Cetuximab_for_Locoregionally_Advanced_Head_and_Neck_Cancer.html</link>
            <description>5-year results from this randomized phase III study of 424 patients with locoregionally advanced, nonmetastatic squamous cell carcinoma of the oropharynx, hypopharynx, or larynx showed that radiotherapy...
Background:... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3045816</comments>
            <pubDate>Wed, 02 Dec 2009 13:47:55 +0100</pubDate>
            <guid isPermaLink="false">3045816</guid>        </item>
        <item>
            <title>Neoadjuvant Chemotherapy Shows Similar Response in Patients With Inflammatory or Locally Advanced Breast Cancer When Compared With Operable Breast Cancer</title>
            <link>http://www.medworm.com/index.php?rid=3040853&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FNeoadjuvant_Chemotherapy_Shows_Similar_Response_in_Patients_With_Inflammatory_or_Locally_Advanced_Breast_Cancer_When_Compared_With_Operable_Breast_Cancer.html</link>
            <description>Among patients with inflammatory and locally advanced breast cancer, the pattern of response to neoadjuvant chemotherapy is not significantly different from that in patients with operable breast cancer....
Related... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3040853</comments>
            <pubDate>Tue, 01 Dec 2009 14:06:43 +0100</pubDate>
            <guid isPermaLink="false">3040853</guid>        </item>
        <item>
            <title>Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience</title>
            <link>http://www.medworm.com/index.php?rid=3040852&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FCytoreductive_Surgery_and_Hyperthermic_Intraperitoneal_Chemotherapy_for_Malignant_Peritoneal_Mesothelioma_Multi_Institutional_Experience.html</link>
            <description>Diffuse malignant peritoneal mesothelioma (DMPM) is a rare disease that carries a poor prognosis. In this retrospective study of 405 patients cytoreductive surgery combined with hyperthermic intraperitoneal...
Related... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3040852</comments>
            <pubDate>Tue, 01 Dec 2009 14:06:43 +0100</pubDate>
            <guid isPermaLink="false">3040852</guid>        </item>
        <item>
            <title>Inhibition of Syk with fostamatinib disodium has significant clinical activity in non Hodgkin's lymphoma and chronic lymphocytic leukemia</title>
            <link>http://www.medworm.com/index.php?rid=3040851&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FInhibition_of_Syk_with_fostamatinib_disodium_has_significant_clinical_activity_in_non_Hodgkins_lymphoma_and_chronic_lymphocytic_leukemia.html</link>
            <description>Disruption of BCR-induced signaling by inhibition of spleen tyrosine kinase (Syk) represents a novel therapeutic approach to the treatment of indolent non-Hodgkin lymphomas (NHLs). In this phase I/II clinical...
Certain... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3040851</comments>
            <pubDate>Tue, 01 Dec 2009 14:06:43 +0100</pubDate>
            <guid isPermaLink="false">3040851</guid>        </item>
        <item>
            <title>Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis</title>
            <link>http://www.medworm.com/index.php?rid=3040850&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FAbnormal_expression_of_TRIB3_in_colorectal_cancer_a_novel_marker_for_prognosis.html</link>
            <description>This study of 202 patients who underwent surgery for CRC, correlation of tumoral gene expression with clinical parameters showed that high TRIB3 expression was associated with shorter overall– and metachronous...
Background:... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3040850</comments>
            <pubDate>Tue, 01 Dec 2009 14:06:43 +0100</pubDate>
            <guid isPermaLink="false">3040850</guid>        </item>
        <item>
            <title>International Patterns of Practice in Palliative Radiotherapy for Painful Bone Metastases: Evidence-Based Practice?</title>
            <link>http://www.medworm.com/index.php?rid=3040849&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FInternational_Patterns_of_Practice_in_Palliative_Radiotherapy_for_Painful_Bone_Metastases_Evidence_Based_Practice.html</link>
            <description>Despite equivalence of multi-fraction and single-fraction RT for palliation of bone metastases, single-fraction schedules remain underutilized. A survey of 3 global radiation oncology organizations found...
Purpose:... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3040849</comments>
            <pubDate>Tue, 01 Dec 2009 14:06:43 +0100</pubDate>
            <guid isPermaLink="false">3040849</guid>        </item>
        <item>
            <title>Quantitative DNA-Methylation Predicts Survival in Adult Acute Myeloid Leukemia</title>
            <link>http://www.medworm.com/index.php?rid=3023951&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FQuantitative_DNA_Methylation_Predicts_Survival_in_Adult_Acute_Myeloid_Leukemia.html</link>
            <description>Eight lymph nodes need to be removed at radical nephroureterectomy to achieve a 75% probability of finding &gt;1 positive nodes in patients with upper tract urothelial cancer. More accurate LN staging may...
Acute... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3023951</comments>
            <pubDate>Wed, 25 Nov 2009 13:46:49 +0100</pubDate>
            <guid isPermaLink="false">3023951</guid>        </item>
        <item>
            <title>Dose-Dense Adjuvant Doxorubicin and Cyclophosphamide Is Not Associated With Frequent Short-Term Changes in Left Ventricular Ejection Fraction</title>
            <link>http://www.medworm.com/index.php?rid=3019992&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FDose_Dense_Adjuvant_Doxorubicin_and_Cyclophosphamide_Is_Not_Associated_With_Frequent_Short_Term_Changes_in_Left_Ventricular_Ejection_Fraction_Revised.html</link>
            <description>Treatment with dd-AC with or without bevacizumab was not associated with a significantly increased incidence of cardiac toxicity.
Access this article »
... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3019992</comments>
            <pubDate>Tue, 24 Nov 2009 13:52:29 +0100</pubDate>
            <guid isPermaLink="false">3019992</guid>        </item>
        <item>
            <title>Analysis of Factors Influencing Outcome in Patients With In-Transit Malignant Melanoma Undergoing Isolated Limb Perfusion Using Modern Treatment Parameters</title>
            <link>http://www.medworm.com/index.php?rid=3013632&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FAnalysis_of_Factors_Influencing_Outcome_in_Patients_With_In_Transit_Malignant_Melanoma_Undergoing_Isolated_Limb_Perfusion_Using_Modern_Treatment_Parameters.html</link>
            <description>In this single-center study of 91 patients with stage III in-transit extremity melanoma, operative isolated limb perfusion (ILP) was associated with high response rates and long-term survival. ILP treatment...
Access... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3013632</comments>
            <pubDate>Sat, 21 Nov 2009 13:47:36 +0100</pubDate>
            <guid isPermaLink="false">3013632</guid>        </item>
        <item>
            <title>Lymphoproliferative Disorders in Patients Receiving Thiopurines for Inflammatory Bowel Disease: A Prospective Observational Cohort Study</title>
            <link>http://www.medworm.com/index.php?rid=3005320&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FLymphoproliferative_Disorders_in_Patients_Receiving_Thiopurines_for_Inflammatory_Bowel_Disease_A_Prospective_Observational_Cohort_Study.html</link>
            <description>Patients receiving thiopurines for inflammatory bowel disease have an increased risk of developing lymphoproliferative disorders.
Background: Reports of an increased risk of lymphoproliferative disorders... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3005320</comments>
            <pubDate>Thu, 19 Nov 2009 13:50:50 +0100</pubDate>
            <guid isPermaLink="false">3005320</guid>        </item>
        <item>
            <title>Clinical Experiences With Bisphosphonate-Associated Osteonecrosis of the Jaws: Analysis of 21 Cases</title>
            <link>http://www.medworm.com/index.php?rid=3001181&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FClinical_Experiences_With_Bisphosphonate_Associated_Osteonecrosis_of_the_Jaws_Analysis_of_21_Cases.html</link>
            <description>The majority of the cases affected the mandible and were associated with IV zoledronate treatment for bone metastasis. Dentoalveolar trauma to the mandible appeared to be a contributing factor. Conservative...
Purpose:... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3001181</comments>
            <pubDate>Wed, 18 Nov 2009 13:50:11 +0100</pubDate>
            <guid isPermaLink="false">3001181</guid>        </item>
        <item>
            <title>Comparative Survival With Diverse Chemotherapy Regimens for Cancer of Unknown Primary Site: Multiple-Treatments Meta-analysis</title>
            <link>http://www.medworm.com/index.php?rid=2996762&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FComparative_Survival_With_Diverse_Chemotherapy_Regimens_for_Cancer_of_Unknown_Primary_Site_Multiple_Treatments_Meta_analysis.html</link>
            <description>No type of chemotherapy has been solidly proven to prolong survival in patients with cancer of unknown primary site. However, some analyses favour platinum- or taxane-based regimens.
Objectives: To synthesize... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2996762</comments>
            <pubDate>Tue, 17 Nov 2009 13:48:49 +0100</pubDate>
            <guid isPermaLink="false">2996762</guid>        </item>
        <item>
            <title>Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, as Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial</title>
            <link>http://www.medworm.com/index.php?rid=2996761&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FFluorouracil_Epirubicin_and_Cyclophosphamide_With_Either_Docetaxel_or_Vinorelbine_With_or_Without_Trastuzumab_as_Adjuvant_Treatments_of_Breast_Cancer.html</link>
            <description>In this open, phase III, prospective, multicenter trial of adjuvant chemotherapy in patients with node–positive or high-risk node-negative breast cancer, docetaxel was more effective than vinorelbine in...
Access... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2996761</comments>
            <pubDate>Tue, 17 Nov 2009 13:48:49 +0100</pubDate>
            <guid isPermaLink="false">2996761</guid>        </item>
        <item>
            <title>Bortezomib and High Dose Melphalan as Conditioning Regimen Before Autologous Stem Cell Transplantation in Patients With de Novo Multiple Myeloma</title>
            <link>http://www.medworm.com/index.php?rid=2996760&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FBortezomib_and_High_Dose_Melphalan_as_Conditioning_Regimen_Before_Autologous_Stem_Cell_Transplantation_in_Patients_With_de_Novo_Multiple_Myeloma.html</link>
            <description>In this phase II study of 54 patients with newly diagnosed multiple myeloma, pre-transplant conditioning with bortezomib plus high-dose melphalan was safe and effective, resulting in a post-transplant...
Autologous... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2996760</comments>
            <pubDate>Tue, 17 Nov 2009 13:48:49 +0100</pubDate>
            <guid isPermaLink="false">2996760</guid>        </item>
        <item>
            <title>Relapse Risk After Umbilical Cord Blood Transplantation: Enhanced Graft-Versus-Leukemia Effect in Recipients of 2 Units</title>
            <link>http://www.medworm.com/index.php?rid=2996759&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FRelapse_Risk_After_Umbilical_Cord_Blood_Transplantation_Enhanced_Graft_Versus_Leukemia_Effect_in_Recipients_of_2_Units.html</link>
            <description>UCB transplant with 2 partially HLA-matched units enhances graft-vs-leukemia effect and lowers the risk of relapse.
Umbilical cord blood (UCB) transplantation is potentially curative for acute leukemia.... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2996759</comments>
            <pubDate>Tue, 17 Nov 2009 13:48:49 +0100</pubDate>
            <guid isPermaLink="false">2996759</guid>        </item>
        <item>
            <title>Adjuvant Capecitabine in Combination With Docetaxel and Cyclophosphamide Plus Epirubicin for Breast Cancer: An Open-Label, Randomised Controlled Trial</title>
            <link>http://www.medworm.com/index.php?rid=2996758&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FAdjuvant_Capecitabine_in_Combination_With_Docetaxel_and_Cyclophosphamide_Plus_Epirubicin_for_Breast_Cancer_An_Open_Label_Randomised_Controlled_Trial.html</link>
            <description>Recurrence-free survival at 3 years was superior for treatment with a capecitabine regimen over standard agents (93% vs 89%). Adverse effects frequently caused discontinuation of capecitabine, but most...
Background:... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2996758</comments>
            <pubDate>Tue, 17 Nov 2009 13:48:49 +0100</pubDate>
            <guid isPermaLink="false">2996758</guid>        </item>
        <item>
            <title>Clinical Relevance of HER2 Overexpression/Amplification in Patients With Small Tumor Size and Node-Negative Breast Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2990310&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FClinical_Relevance_of_HER2_Overexpression_Amplification_in_Patients_With_Small_Tumor_Size_and_Node_Negative_Breast_Cancer.html</link>
            <description>In this retrospective analysis of 150 patients with HER2-positive pT1a/bN0M0 breast cancer and 229 matched controls, HER2-positive status was associated with a significantly higher risk of recurrence than...
Related... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2990310</comments>
            <pubDate>Sat, 14 Nov 2009 13:48:11 +0100</pubDate>
            <guid isPermaLink="false">2990310</guid>        </item>
        <item>
            <title>High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2–Positive, Node-Negative Tumors 1 cm or Smaller</title>
            <link>http://www.medworm.com/index.php?rid=2990309&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FHigh_Risk_of_Recurrence_for_Patients_With_Breast_Cancer_Who_Have_Human_Epidermal_Growth_Factor_Receptor_2_Positive_Node_Negative_Tumors_1_cm_or_Smaller.html</link>
            <description>In this retrospective study of 935 patients, T1a/T1b HER2-positive breast cancer was associated with more aggressive biology and higher risk of recurrence. The results were validated in a separate cohort...
Related... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2990309</comments>
            <pubDate>Sat, 14 Nov 2009 13:48:11 +0100</pubDate>
            <guid isPermaLink="false">2990309</guid>        </item>
        <item>
            <title>A Prospective Cohort Study Shows Unique Epigenetic, Genetic, and Prognostic Features of Synchronous Colorectal Cancers</title>
            <link>http://www.medworm.com/index.php?rid=2982457&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FA_Prospective_Cohort_Study_Shows_Unique_Epigenetic_Genetic_and_Prognostic_Features_of_Synchronous_Colorectal_Cancers.html</link>
            <description>Synchronous CRC tumors were more likely than solitary cancers to have BRAF mutations, high microsatellite instability, and CIMP.
Background &amp; Aims: Synchronous colorectal neoplasias (2 or more primary... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2982457</comments>
            <pubDate>Thu, 12 Nov 2009 13:49:43 +0100</pubDate>
            <guid isPermaLink="false">2982457</guid>        </item>
        <item>
            <title>Calibration and Discriminatory Accuracy of Prognosis Calculation for Breast Cancer With the Online Adjuvant! Program: A Hospital-Based Retrospective Cohort Study</title>
            <link>http://www.medworm.com/index.php?rid=2982456&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FCalibration_and_Discriminatory_Accuracy_of_Prognosis_Calculation_for_Breast_Cancer_With_the_Online_Adjuvant_Program_A_Hospital_Based_Retrospective_Cohort_Study.html</link>
            <description>Large-scale Dutch study validated Adjuvant! as accurately predicting 10-year outcomes in patients with breast cancer.
Background: Adjuvant! is a web-based program that calculates individualised 10-year... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2982456</comments>
            <pubDate>Thu, 12 Nov 2009 13:49:43 +0100</pubDate>
            <guid isPermaLink="false">2982456</guid>        </item>
        <item>
            <title>Neurocognition in Patients With Brain Metastases Treated With Radiosurgery or Radiosurgery Plus Whole-Brain Irradiation: A Randomised Controlled Trial</title>
            <link>http://www.medworm.com/index.php?rid=2982455&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FNeurocognition_in_Patients_With_Brain_Metastases_Treated_With_Radiosurgery_or_Radiosurgery_Plus_Whole_Brain_Irradiation_A_Randomised_Controlled_Trial.html</link>
            <description>Patients with newly diagnosed brain metastasis who were randomly assigned to SRS plus WBRT (28) were more likely to show a significant drop in HVLT–R total recall at 4 months than were patients randomly...
Background:... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2982455</comments>
            <pubDate>Thu, 12 Nov 2009 13:49:43 +0100</pubDate>
            <guid isPermaLink="false">2982455</guid>        </item>
        <item>
            <title>VMP (Bortezomib, Melphalan, and Prednisone) Is Active and Well Tolerated in Newly Diagnosed Patients With Multiple Myeloma With Moderately Impaired Renal Function</title>
            <link>http://www.medworm.com/index.php?rid=2974808&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FVMP_Bortezomib_Melphalan_and_Prednisone_Is_Active_and_Well_Tolerated_in_Newly_Diagnosed_Patients_With_Multiple_Myeloma_With_Moderately_Impaired_Renal_Function.html</link>
            <description>Cohort analysis of the VISTA data showed that VMP was well tolerated and was superior to MP in patients with moderate renal impairment, reversing impairment in 44%.
Related Links:
Access this article... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2974808</comments>
            <pubDate>Tue, 10 Nov 2009 13:49:13 +0100</pubDate>
            <guid isPermaLink="false">2974808</guid>        </item>
        <item>
            <title>Long Term Outcome of EBV Specific T-Cell Infusions to Prevent or Treat EBV-Related Lymphoproliferative Disease in Transplant Recipients</title>
            <link>http://www.medworm.com/index.php?rid=2974807&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FLong_Term_Outcome_of_EBV_Specific_T_Cell_Infusions_to_Prevent_or_Treat_EBV_Related_Lymphoproliferative_Disease_in_Transplant_Recipients.html</link>
            <description>EBV-specific cytotoxic T lymphocytes safely prevented or treated lymphoproliferative disease in SCT recipients.
T-cell immunotherapy that takes advantage of Epstein-Barr virus (EBV)-stimulated immunity... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2974807</comments>
            <pubDate>Tue, 10 Nov 2009 13:49:13 +0100</pubDate>
            <guid isPermaLink="false">2974807</guid>        </item>
        <item>
            <title>High-Dose Cytarabine Plus High-Dose Methotrexate Versus High-Dose Methotrexate Alone in Patients With Primary CNS Lymphoma: A Randomised Phase 2 Trial</title>
            <link>http://www.medworm.com/index.php?rid=2974806&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FHigh_Dose_Cytarabine_Plus_High_Dose_Methotrexate_Versus_High_Dose_Methotrexate_Alone_in_Patients_With_Primary_CNS_Lymphoma_A_Randomised_Phase_2_Trial.html</link>
            <description>The complete remission rate was 46% with high-dose cytarabine plus high-dose methotrexate compared with 18% for high-dose methotrexate alone in patients with in CNS lymphoma.
Background: Chemotherapy... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2974806</comments>
            <pubDate>Tue, 10 Nov 2009 13:49:13 +0100</pubDate>
            <guid isPermaLink="false">2974806</guid>        </item>
        <item>
            <title>Development and Validation of a Prognostic Nomogram for Recurrence-Free Survival After Complete Surgical Resection of Localised Primary Gastrointestinal Stromal Tumour</title>
            <link>http://www.medworm.com/index.php?rid=2974805&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FDevelopment_and_Validation_of_a_Prognostic_Nomogram_for_Recurrence-Free_Survival_After_Complete_Surgical_Resection_of_Localised_Primary_Gastrointestinal_Stromal_Tumour.html</link>
            <description>Nomogram based on tumor size, location, and mitotic index predicts RFS after resection of localized primary GIST.
Background: Adjuvant imatinib mesylate prolongs recurrence-free survival (RFS) after resection... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2974805</comments>
            <pubDate>Tue, 10 Nov 2009 13:49:13 +0100</pubDate>
            <guid isPermaLink="false">2974805</guid>        </item>
        <item>
            <title>Epidemiological Study on Survival of Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL) Patients With BCR-ABL T315I Mutation</title>
            <link>http://www.medworm.com/index.php?rid=2968560&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FEpidemiological_Study_on_Survival_of_Chronic_Myeloid_Leukemia_CML_and_Ph_Acute_Lymphoblastic_Leukemia_ALL_Patients_With_BCR_ABL_T315I_Mutation.html</link>
            <description>In patients with BCR-ABL–positive (Ph+) leukemia, the T315I mutation is associated with a high degree of resistance to imatinib, dasatinib, and nilotinib. Little published information exits regarding the...
The... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2968560</comments>
            <pubDate>Sat, 07 Nov 2009 13:48:11 +0100</pubDate>
            <guid isPermaLink="false">2968560</guid>        </item>
        <item>
            <title>Advances in Imaging in the Work-Up of Head and Neck Cancer Patients</title>
            <link>http://www.medworm.com/index.php?rid=2968559&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FAdvances_in_Imaging_in_the_Work_Up_of_Head_and_Neck_Cancer_Patients.html</link>
            <description>Current roles of CT and MRI in diagnosing HNSCC are discussed, along with the value of FDG-PET-CT in detecting occult LN metastases.
Accurate staging at the time of the diagnosis of head and neck squamous... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2968559</comments>
            <pubDate>Sat, 07 Nov 2009 13:48:11 +0100</pubDate>
            <guid isPermaLink="false">2968559</guid>        </item>
        <item>
            <title>Surgical Management of Liver Metastases From Uveal Melanoma: 16 Years' Experience at the Institut Curie</title>
            <link>http://www.medworm.com/index.php?rid=2960403&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FSurgical_Management_of_Liver_Metastases_From_Uveal_Melanoma_16_Years_Experience_at_the_Institut_Curie.html</link>
            <description>R0 surgical resection almost doubled survival, to 27 months, in this single-institution experience.
Background: Uveal melanoma is characterised by a high prevalence of liver metastases and a poor prognosis.
Aim:... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2960403</comments>
            <pubDate>Thu, 05 Nov 2009 13:48:51 +0100</pubDate>
            <guid isPermaLink="false">2960403</guid>        </item>
        <item>
            <title>Predictive Value of FIGO and AJCC Staging Systems in Patients With Uterine Leiomyosarcoma</title>
            <link>http://www.medworm.com/index.php?rid=2960402&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FPredictive_Value_of_FIGO_and_AJCC_Staging_Systems_in_Patients_With_Uterine_Leiomyosarcoma.html</link>
            <description>Neither the FIGO nor the AJCC system adequately classifies ULMS patients into clinically meaningful prognostic groups.
Background: Cancer staging systems aim to identify patient cohorts with different... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2960402</comments>
            <pubDate>Thu, 05 Nov 2009 13:48:51 +0100</pubDate>
            <guid isPermaLink="false">2960402</guid>        </item>
        <item>
            <title>Cancer During Pregnancy: An Analysis of 215 Patients Emphasizing the Obstetrical and the Neonatal Outcomes</title>
            <link>http://www.medworm.com/index.php?rid=2944951&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FCancer_During_Pregnancy_An_Analysis_of_215_Patients_Emphasizing_the_Obstetrical_and_the_Neonatal_Outcomes.html</link>
            <description>In this observational study of pregnancy outcomes in 215 women with invasive cancer, a substantial percentage of babies (54.2%) were born preterm. The majority of the preterm babies (85.2%) required admission...
Access... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2944951</comments>
            <pubDate>Sat, 31 Oct 2009 13:47:57 +0100</pubDate>
            <guid isPermaLink="false">2944951</guid>        </item>
        <item>
            <title>Randomized Phase III Trial on Gemcitabine Versus Mytomicin in Recurrent Superficial Bladder Cancer: Evaluation of Efficacy and Tolerance</title>
            <link>http://www.medworm.com/index.php?rid=2944950&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FRandomized_Phase_III_Trial_on_Gemcitabine_Versus_Mytomicin_in_Recurrent_Superficial_Bladder_Cancer_Evaluation_of_Efficacy_and_Tolerance.html</link>
            <description>Despite adjuvant BCG therapy after transurethral resection for superficial bladder cancer, recurrence often occurs. In this randomized, phase III study of 109 patients with recurrent stage T1/T1a bladder...
Access... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2944950</comments>
            <pubDate>Sat, 31 Oct 2009 13:47:57 +0100</pubDate>
            <guid isPermaLink="false">2944950</guid>        </item>
        <item>
            <title>Nilotinib for the frontline treatment of Ph+ chronic myeloid leukemia</title>
            <link>http://www.medworm.com/index.php?rid=2928368&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FNilotinib_for_the_frontline_treatment_of_Ph_chronic_myeloid_leukemia.html</link>
            <description>In this phase II study of 73 patients with untreated, Ph+, early-phase CML, nilotinib 400 mg twice daily was associated with a 1-year complete cytogenetic response rate of 96% and a major molecular response...
Nilotinib... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2928368</comments>
            <pubDate>Tue, 27 Oct 2009 13:50:14 +0100</pubDate>
            <guid isPermaLink="false">2928368</guid>        </item>
        <item>
            <title>T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics and outcome from the large randomised prospective trial</title>
            <link>http://www.medworm.com/index.php?rid=2928367&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FT_cell_acute_lymphoblastic_leukemia_in_adults_clinical_features_immunophenotype_cytogenetics_and_outcome_from_the_large_randomised_prospective_trial.html</link>
            <description>No standard of care exists for patients with adult T-lineage acute lymphoblastic leukemia (ALL). In this prospective, randomized trial of 356 patients, Marks et al describe clinical features, cytogenetics...
The... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2928367</comments>
            <pubDate>Tue, 27 Oct 2009 13:50:14 +0100</pubDate>
            <guid isPermaLink="false">2928367</guid>        </item>
        <item>
            <title>Evidence of serum immunoglobulin abnormalities up to 9.8 years prior to diagnosis of chronic lymphocytic leukemia: a prospective study</title>
            <link>http://www.medworm.com/index.php?rid=2928366&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FEvidence_of_serum_immunoglobulin_abnormalities_up_to_9_8_years_prior_to_diagnosis_of_chronic_lymphocytic_leukemia_a_prospective_study.html</link>
            <description>In this study of 109 patients who were identified during the PLCO Cancer Screening Trial, abnormal free light chain ratio and M-protein level preceded diagnosis of CLL by to 10 years. Hypogammaglobinemia...
Immune-related... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2928366</comments>
            <pubDate>Tue, 27 Oct 2009 13:50:14 +0100</pubDate>
            <guid isPermaLink="false">2928366</guid>        </item>
        <item>
            <title>Acute dasatinib exposure commits Bcr-Abl-dependent cells to apoptosis</title>
            <link>http://www.medworm.com/index.php?rid=2928365&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FAcute_dasatinib_exposure_commits_Bcr_Abl_dependent_cells_to_apoptosis.html</link>
            <description>In vitro studies conducted in progenitor cells from patients with chronic-phase chronic myeloid leukemia demonstrated that transient Bcr-Abl inhibition using dasatinib or nilotinib induced apoptosis. This...
Pioneering... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2928365</comments>
            <pubDate>Tue, 27 Oct 2009 13:50:14 +0100</pubDate>
            <guid isPermaLink="false">2928365</guid>        </item>
        <item>
            <title>Clinical Outcome of Dose-Escalated Image-Guided Radiotherapy for Spinal Metastases</title>
            <link>http://www.medworm.com/index.php?rid=2928364&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FClinical_Outcome_of_Dose_Escalated_Image_Guided_Radiotherapy_for_Spinal_Metastases.html</link>
            <description>Excellent local control of spinal metastases and paraspinal tumors was achieved with dose-escalated irradiation.
Purpose: To evaluate the outcomes after dose-escalated radiotherapy (RT) for spinal metastases... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2928364</comments>
            <pubDate>Tue, 27 Oct 2009 13:50:14 +0100</pubDate>
            <guid isPermaLink="false">2928364</guid>        </item>
        <item>
            <title>Preoperative Intensity-Modulated Radiotherapy Combined with Temozolomide for Locally Advanced Soft-Tissue Sarcoma</title>
            <link>http://www.medworm.com/index.php?rid=2928363&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FPreoperative_Intensity_Modulated_Radiotherapy_Combined_with_Temozolomide_for_Locally_Advanced_Soft_Tissue_Sarcoma.html</link>
            <description>Intensity-modulated radiotherapy plus temozolomide was safe and effective before surgery for soft-tissue sarcoma.
Purpose: To evaluate the toxicity and efficacy of preoperative intensity-modulated radiotherapy... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2928363</comments>
            <pubDate>Tue, 27 Oct 2009 13:50:14 +0100</pubDate>
            <guid isPermaLink="false">2928363</guid>        </item>
        <item>
            <title>Alpha-Fetoprotein Response After Locoregional Therapy for Hepatocellular Carcinoma: Oncologic Marker of Radiologic Response, Progression, and Survival</title>
            <link>http://www.medworm.com/index.php?rid=2921383&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FAlpha_Fetoprotein_Response_After_Locoregional_Therapy_for_Hepatocellular_Carcinoma_Oncologic_Marker_of_Radiologic_Response_Progression_and_Survival.html</link>
            <description>AFP response was a prognostic indicator for radiologic tumor response and OS in patients receiving locoregional therapy for HCC.
Access this article »
... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2921383</comments>
            <pubDate>Sat, 24 Oct 2009 12:47:17 +0100</pubDate>
            <guid isPermaLink="false">2921383</guid>        </item>
        <item>
            <title>Local Excision Alone Without Irradiation for Ductal Carcinoma in Situ of the Breast: A Trial of the Eastern Cooperative Oncology Group</title>
            <link>http://www.medworm.com/index.php?rid=2921382&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FLocal_Excision_Alone_Without_Irradiation_for_Ductal_Carcinoma_in_Situ_of_the_Breast_A_Trial_of_the_Eastern_Cooperative_Oncology_Group.html</link>
            <description>In this prospective analysis, women with low- and intermediate-grade ductal carcinoma in situ of the breast (n = 565) were at low risk (6%) for recurrence at 5 years after excision without radiation therapy....
Access... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2921382</comments>
            <pubDate>Sat, 24 Oct 2009 12:47:17 +0100</pubDate>
            <guid isPermaLink="false">2921382</guid>        </item>
        <item>
            <title>Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera</title>
            <link>http://www.medworm.com/index.php?rid=2921381&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FPegylated_Interferon_Alfa_2a_Yields_High_Rates_of_Hematologic_and_Molecular_Response_in_Patients_With_Advanced_Essential_Thrombocythemia_and_Polycythemia_Vera.html</link>
            <description>In this prospective, open-label, single-center, phase II trial of PEGIFN-2a in 70 patients with advanced ET or PV, PEGIFN-2a was effective and well tolerated at 90 µg weekly. PEG-IFN-2a was associated...
Access... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2921381</comments>
            <pubDate>Sat, 24 Oct 2009 12:47:17 +0100</pubDate>
            <guid isPermaLink="false">2921381</guid>        </item>
        <item>
            <title>Venous Thromboembolism in Lymphoma: How Effectively Are We Treating Patients?</title>
            <link>http://www.medworm.com/index.php?rid=2909920&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FVenous_Thromboembolism_in_Lymphoma_How_Effectively_Are_We_Treating_Patients.html</link>
            <description>Warfarin treatment in lymphoma patients was linked with a 30% rate of recurrent thrombosis and a 13% rate of major bleeding.
Introduction: Patients with solid tumors and venous thromboembolic episodes... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2909920</comments>
            <pubDate>Wed, 21 Oct 2009 12:52:15 +0100</pubDate>
            <guid isPermaLink="false">2909920</guid>        </item>
        <item>
            <title>Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemotherapy</title>
            <link>http://www.medworm.com/index.php?rid=2905957&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FMultinational_Double-Blind_Phase_III_Study_of_Prednisone_and_Either_Satraplatin_or_Placebo_in_Patients_With_Castrate_Refractory_Prostate_Cancer_Progressing_After_Prior_Chemotherapy.html</link>
            <description>This randomized phase III study of 950 patients with castrate-refractory prostate cancer compared the efficacy of satraplatin plus prednisone with that of prednisone alone. Satraplatin plus prednisone...
Access... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2905957</comments>
            <pubDate>Tue, 20 Oct 2009 12:48:35 +0100</pubDate>
            <guid isPermaLink="false">2905957</guid>        </item>
        <item>
            <title>Phase III Trial of Casopitant, a Novel Neurokinin-1 Receptor Antagonist, for the Prevention of Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy</title>
            <link>http://www.medworm.com/index.php?rid=2905956&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FPhase_III_Trial_of_Casopitant_a_Novel_Neurokinin_1_Receptor_Antagonist_for_the_Prevention_of_Nausea_and_Vomiting_in_Patients_Receiving_Moderately_Emetogenic_Chemotherapy.html</link>
            <description>Results of this randomized, controlled, parallel-group, phase III clinical trial of 1933 patients showed that addition of casopitant to ondansetron and dexamethasone was effective in preventing chemotherapy-induced...
Access... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2905956</comments>
            <pubDate>Tue, 20 Oct 2009 12:48:35 +0100</pubDate>
            <guid isPermaLink="false">2905956</guid>        </item>
        <item>
            <title>AML1/RUNX1 Mutations in 470 Adult Patients With de Novo Acute Myeloid Leukemia: Prognostic Implication and Interaction With Other Gene Alterations</title>
            <link>http://www.medworm.com/index.php?rid=2905955&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FAML1_RUNX1_Mutations_in_470_Adult_Patients_With_de_Novo_Acute_Myeloid_Leukemia_Prognostic_Implication_and_Interaction_With_Other_Gene_Alterations.html</link>
            <description>RUNX1 mutation was an independent prognostic factor for poor overall survival in patients with de novo AML.
Somatic mutation of AML1/RUNX1(RUNX1) gene is seen in acute myeloid leukemia (AML) M0 subtype... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2905955</comments>
            <pubDate>Tue, 20 Oct 2009 12:48:35 +0100</pubDate>
            <guid isPermaLink="false">2905955</guid>        </item>
        <item>
            <title>Surgery With Curative-Intent in Patients Treated With First-Line Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer. First BEAT and the Randomised Phase-III NO16966 Trial</title>
            <link>http://www.medworm.com/index.php?rid=2905954&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FSurgery_With_Curative_Intent_in_Patients_Treated_With_First_Line_Chemotherapy_Plus_Bevacizumab_for_Metastatic_Colorectal_Cancer_First_BEAT_and_the_Randomised_Phase_III_NO16966_Trial.html</link>
            <description>Two studies, First BEAT and NO16966 Trial, evaluated the safety and survival effect of bevacizumab in patients undergoing surgery for metastatic colorectal cancer.
Background: Complete resection of metastases... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2905954</comments>
            <pubDate>Tue, 20 Oct 2009 12:48:35 +0100</pubDate>
            <guid isPermaLink="false">2905954</guid>        </item>
        <item>
            <title>Allogeneic Stem Cell Transplantation After Reduced-Intensity Conditioning in Patients With Myelofibrosis</title>
            <link>http://www.medworm.com/index.php?rid=2905953&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FAllogeneic_Stem_Cell_Transplantation_After_Reduced_Intensity_Conditioning_in_Patients_With_Myelofibrosis.html</link>
            <description>The prospective multicenter phase II study evaluated the use of reduced intensity conditioning (RIC) with busulfan plus fludarabine in patients with primary myelofibrosis. RIC was followed by allogeneic...
From... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2905953</comments>
            <pubDate>Tue, 20 Oct 2009 12:48:35 +0100</pubDate>
            <guid isPermaLink="false">2905953</guid>        </item>
        <item>
            <title>Risk of Bleeding With Vascular Endothelial Growth Factor Receptor Tyrosine-Kinase Inhibitors Sunitinib and Sorafenib: A Systematic Review and Meta-analysis of Clinical Trials</title>
            <link>http://www.medworm.com/index.php?rid=2900230&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FRisk_of_Bleeding_With_Vascular_Endothelial_Growth_Factor_Receptor_Tyrosine_Kinase_Inhibitors_Sunitinib_and_Sorafenib_A_Systematic_Review_and_Meta_analysis_of_Clinical_Trials.html</link>
            <description>In this meta-analysis of nearly 7000 patients, sunitinib and sorafenib significantly increased the risk of bleeding. Clinicians should be aware of the possibility of increased bleeding, especially in patients...
Background:... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2900230</comments>
            <pubDate>Sat, 17 Oct 2009 12:46:50 +0100</pubDate>
            <guid isPermaLink="false">2900230</guid>        </item>
        <item>
            <title>AML With Mutated NPM1 Carrying a Normal or Aberrant Karyotype Show Overlapping Biologic, Pathologic, Immunophenotypic, and Prognostic Features</title>
            <link>http://www.medworm.com/index.php?rid=2900229&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FAML_With_Mutated_NPM1_Carrying_a_Normal_or_Aberrant_Karyotype_Show_Overlapping_Biologic_Pathologic_Immunophenotypic_and_Prognostic_Features.html</link>
            <description>Results of this study of 631 patients with AML strongly suggest that the NPM1 gene mutation, which is present in 30% of adult AML cases, is at the root of the underlying disease mechanism in AML. Concomitant...
Acute... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2900229</comments>
            <pubDate>Sat, 17 Oct 2009 12:46:50 +0100</pubDate>
            <guid isPermaLink="false">2900229</guid>        </item>
        <item>
            <title>Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy Is Accurate and Reduces the Need for Axillary Dissection in Breast Cancer Patients</title>
            <link>http://www.medworm.com/index.php?rid=2900228&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FSentinel_Lymph_Node_Surgery_After_Neoadjuvant_Chemotherapy_Is_Accurate_and_Reduces_the_Need_for_Axillary_Dissection_in_Breast_Cancer_Patients.html</link>
            <description>In this study of 3746 women with node-negative T1-T3 breast cancer, sentinel lymph node surgery after neoadjuvant chemotherapy had similar detection rates and false-negative rates when compared with surgery...
Objective:... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2900228</comments>
            <pubDate>Sat, 17 Oct 2009 12:46:50 +0100</pubDate>
            <guid isPermaLink="false">2900228</guid>        </item>
        <item>
            <title>A Population-Based Analysis of the Rate of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the United States</title>
            <link>http://www.medworm.com/index.php?rid=2887839&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FA_Population_Based_Analysis_of_the_Rate_of_Cytoreductive_Nephrectomy_for_Metastatic_Renal_Cell_Carcinoma_in_the_United_States.html</link>
            <description>Although cytoreductive nephrectomy improves survival in patients with mRCC, racial and geographic variability in its use is worrisome.
Objective: To examine temporal, geographic, socioeconomic, and clinical... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2887839</comments>
            <pubDate>Wed, 14 Oct 2009 12:48:11 +0100</pubDate>
            <guid isPermaLink="false">2887839</guid>        </item>
        <item>
            <title>Abnormal Serum Free Light Chain Ratio in Patients With Multiple Myeloma in Complete Remission Has Strong Association With the Presence of Oligoclonal Bands: Implications for Stringent Complete Remission Definition</title>
            <link>http://www.medworm.com/index.php?rid=2887838&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FAbnormal_Serum_Free_Light_Chain_Ratio_in_Patients_With_Multiple_Myeloma_in_Complete_Remission_Has_Strong_Association_With_the_Presence_of_Oligoclonal_Bands.html</link>
            <description>The correlation between abnormal FLC ratio and oligoclonal bands in patients with MM in complete response may have implications for the current definition of stringent CR.
The prevalence of an abnormal... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2887838</comments>
            <pubDate>Wed, 14 Oct 2009 12:48:11 +0100</pubDate>
            <guid isPermaLink="false">2887838</guid>        </item>
        <item>
            <title>Chronic Myeloid Leukemia: A Prospective Comparison of Interphase Fluorescence in Situ Hybridization and Chromosome Banding Analysis for the Definition of Complete Cytogenetic Response</title>
            <link>http://www.medworm.com/index.php?rid=2887837&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FChronic_Myeloid_Leukemia_A_Prospective_Comparison_of_Interphase_Fluorescence_in_Situ_Hybridization_and_Chromosome_Banding_Analysis_for_the_Definition_of_Complete_Cytogenetic_Response.html</link>
            <description>Interphase-FISH is more sensitive than chromosome banding analysis and can be used to monitor complete cytogenetic response. The cut-off value of Interphase-FISH may be established at 1%.
In chronic myeloid... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2887837</comments>
            <pubDate>Wed, 14 Oct 2009 12:48:11 +0100</pubDate>
            <guid isPermaLink="false">2887837</guid>        </item>
        <item>
            <title>High Id1 Expression Is Associated With Poor Prognosis in 237 Patients With Acute Myeloid Leukemia</title>
            <link>http://www.medworm.com/index.php?rid=2887836&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FHigh_Id1_Expression_Is_Associated_With_Poor_Prognosis_in_237_Patients_With_Acute_Myeloid_Leukemia.html</link>
            <description>In patients with AML, especially those age 60 years, high Id1 expression independently predicted shorter DFS and OS. Id1 expression may thus be a new molecular marker useful in risk classification.
Inhibitors... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2887836</comments>
            <pubDate>Wed, 14 Oct 2009 12:48:11 +0100</pubDate>
            <guid isPermaLink="false">2887836</guid>        </item>
        <item>
            <title>Can Chemotherapy Be Discontinued in Unresectable Metastatic Colorectal Cancer? The GERCOR OPTIMOX2 Study</title>
            <link>http://www.medworm.com/index.php?rid=2883872&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FCan_Chemotherapy_Be_Discontinued_in_Unresectable_Metastatic_Colorectal_Cancer_The_GERCOR_OPTIMOX2_Study.html</link>
            <description>The results of the OPTIMAX2 study showed that maintenance therapy with simplified LV5FU2 between induction and reintroduction with mFOLFOX7 reduced the risk of oxaliplatin failure by 29% when compared...
Access... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2883872</comments>
            <pubDate>Tue, 13 Oct 2009 12:53:53 +0100</pubDate>
            <guid isPermaLink="false">2883872</guid>        </item>
        <item>
            <title>Defining Prior Therapy in Myelodysplastic Syndromes and Criteria for Relapsed and Refractory Disease: Implications for Clinical Trial Design and Enrollment</title>
            <link>http://www.medworm.com/index.php?rid=2870141&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FDefining_Prior_Therapy_in_Myelodysplastic_Syndromes_and_Criteria_for_Relapsed_and_Refractory_Disease_Implications_for_Clinical_Trial_Design_and_Enrollment.html</link>
            <description>The recent approval of 3 drugs for the treatment of myelodysplastic syndromes (MDSs) has resulted in a revolution in therapeutic options that was absent a decade ago. At the same time, the changing MDS... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2870141</comments>
            <pubDate>Thu, 08 Oct 2009 09:02:56 +0100</pubDate>
            <guid isPermaLink="false">2870141</guid>        </item>
        <item>
            <title>Factors Associated With Clinical Benefit From Epidermal Growth Factor Receptor Inhibitors in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck</title>
            <link>http://www.medworm.com/index.php?rid=2870140&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FFactors_Associated_With_Clinical_Benefit_From_Epidermal_Growth_Factor_Receptor_Inhibitors_in_Recurrent_and_Metastatic_Squamous_Cell_Carcinoma_of_the_Head_and_Neck.html</link>
            <description>Older age, better performance status, and rash were related to clinical benefit from EGFR treatment for head and neck cancer.
Single agent epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2870140</comments>
            <pubDate>Thu, 08 Oct 2009 09:02:56 +0100</pubDate>
            <guid isPermaLink="false">2870140</guid>        </item>
        <item>
            <title>Association of Age and Survival in Patients With Gastroesophageal Cancer Undergoing Surgery With or Without Preoperative Therapy</title>
            <link>http://www.medworm.com/index.php?rid=2870139&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FAssociation_of_Age_and_Survival_in_Patients_With_Gastroesophageal_Cancer_Undergoing_Surgery_With_or_Without_Preoperative_Therapy.html</link>
            <description>In this retrospective analysis of 600 patients with esophageal cancer, patients &gt;60 years of age and especially those &gt;70 years had shorter long-term OS and DFS and more postoperative complications than...
Background:... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2870139</comments>
            <pubDate>Thu, 08 Oct 2009 09:02:56 +0100</pubDate>
            <guid isPermaLink="false">2870139</guid>        </item>
        <item>
            <title>Dasatinib Treatment of Chronic Phase Chronic Myeloid Leukemia: Analysis of Responses According to Preexisting BCR-ABL Mutations</title>
            <link>http://www.medworm.com/index.php?rid=2863595&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FDasatinib_Treatment_of_Chronic_Phase_Chronic_Myeloid_Leukemia_Analysis_of_Responses_According_to_Preexisting_BCR-ABL_Mutations.html</link>
            <description>In this study of 1043 patients, dasatinib was associated with durable responses in patients with chronic phase CML who had progressive disease after prior imatinib treatment, regardless of BCR-ABL mut...
Dasatinib... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2863595</comments>
            <pubDate>Tue, 06 Oct 2009 16:17:51 +0100</pubDate>
            <guid isPermaLink="false">2863595</guid>        </item>
        <item>
            <title>Cost of a 5-Year Lung Cancer Survivor: Symptomatic Tumour Identification vs Proactive Computed Tomography Screening</title>
            <link>http://www.medworm.com/index.php?rid=2839890&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FCost_of_a_5-Year_Lung_Cancer_Survivor_Symptomatic_Tumour_Identification_vs_Proactive_Computed_Tomography_Screening.html</link>
            <description>The cost per 5-year survivor was considerably lower with CT screening than with the symptom-detected approach, especially for patients over age 60, and the number of 5-year survivors was greater.
Background:... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2839890</comments>
            <pubDate>Tue, 29 Sep 2009 16:16:49 +0100</pubDate>
            <guid isPermaLink="false">2839890</guid>        </item>
        <item>
            <title>Interim Positron Emission Tomography (PET) Scans in Diffuse Large B-Cell Lymphoma</title>
            <link>http://www.medworm.com/index.php?rid=2839889&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FInterim_Positron_Emission_Tomography_PET_Scans_in_Diffuse_Large_B-Cell_Lymphoma.html</link>
            <description>Scoring of interim PET scans by nuclear medicine experts showed only moderate consistency (16% to 34% range for PET+ scans).
Positive interim-PET scans are thought to be associated with inferior outcomes... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2839889</comments>
            <pubDate>Tue, 29 Sep 2009 16:16:49 +0100</pubDate>
            <guid isPermaLink="false">2839889</guid>        </item>
        <item>
            <title>Combined Liver Surgery and RFA for Patients With Gastroenteropancreatic Endocrine Tumors Presenting With More Than 15 Metastases to the Liver</title>
            <link>http://www.medworm.com/index.php?rid=2839888&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FCombined_Liver_Surgery_and_RFA_for_Patients_With_Gastroenteropancreatic_Endocrine_Tumors_Presenting_With_More_Than_15_Metastases_to_the_Liver.html</link>
            <description>Use of a 1-step approach in patients with 23 liver mets (median) permitted upgraded therapy and yielded improved prognosis.
Aim: The aim of this study was to report the feasibility and early survival... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2839888</comments>
            <pubDate>Tue, 29 Sep 2009 16:16:49 +0100</pubDate>
            <guid isPermaLink="false">2839888</guid>        </item>
        <item>
            <title>Anthracycline Dose Intensification in Acute Myeloid Leukemia</title>
            <link>http://www.medworm.com/index.php?rid=2833128&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FAnthracycline_Dose_Intensification_in_Acute_Myeloid_Leukemia.html</link>
            <description>In this randomized phase III study of 657 patients (age, 17 to 60 years) who had treatment-naïve acute myeloid leukemia, induction therapy with cytarabine plus high-dose daunorubicin (90 mg) was associated...
Background:... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2833128</comments>
            <pubDate>Sat, 26 Sep 2009 16:14:51 +0100</pubDate>
            <guid isPermaLink="false">2833128</guid>        </item>
        <item>
            <title>Positron Emission Tomography for Monitoring Response to Neoadjuvant Therapy in Patients With Oesophageal and Gastro-oesophageal Junction Carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=2825771&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FPositron_Emission_Tomography_for_Monitoring_Response_to_Neoadjuvant_Therapy_in_Patients_With_Oesophageal_and_Gastro_oesophageal_Junction_Carcinoma.html</link>
            <description>Review of 22 studies reveals variations in the ability to predict pathologic response and survival outcomes using PET data.
Aims: The aim of this review is to consolidate our knowledge on an important... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2825771</comments>
            <pubDate>Thu, 24 Sep 2009 16:14:56 +0100</pubDate>
            <guid isPermaLink="false">2825771</guid>        </item>
        <item>
            <title>5-Year Survival in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia in a Randomized, Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen</title>
            <link>http://www.medworm.com/index.php?rid=2815756&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2F5_Year_Survival_in_Patients_With_Relapsed_or_Refractory_Chronic_Lymphocytic_Leukemia_in_a_Randomized_Phase_III_Trial_of_Fludarabine_Plus_Cyclophosphamide_With_or_Without_Oblimersen.html</link>
            <description>In this randomized phase III trial of FC with or without oblimersen, the addition of oblimersen to therapy was associated with a significant survival benefit in a subgroup of patients with relapsed or...
Related... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2815756</comments>
            <pubDate>Tue, 22 Sep 2009 16:16:18 +0100</pubDate>
            <guid isPermaLink="false">2815756</guid>        </item>
        <item>
            <title>VH4-34+ Hairy Cell Leukemia, a New Variant With Poor Prognosis Despite Standard Therapy</title>
            <link>http://www.medworm.com/index.php?rid=2815755&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FVH4_34_Hairy_Cell_Leukemia_a_New_Variant_With_Poor_Prognosis_Despite_Standard_Therapy.html</link>
            <description>VH4-34 status relates to poorer response to cladribine and shorter survival among patients with HCLv.
Hairy cell leukemia variant (HCLv) presents with high disease burden, lack of typical antigens like... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2815755</comments>
            <pubDate>Tue, 22 Sep 2009 16:16:18 +0100</pubDate>
            <guid isPermaLink="false">2815755</guid>        </item>
        <item>
            <title>Chronic Myeloid Leukemia (CML) With P190BCR-ABL: Analysis of Characteristics, Outcomes, and Prognostic Significance</title>
            <link>http://www.medworm.com/index.php?rid=2815754&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FChronic_Myeloid_Leukemia_CML_With_P190BCR_ABL_Analysis_of_Characteristics_Outcomes_and_Prognostic_Significance.html</link>
            <description>Although P190BCR-ABL transcript in CML is rare (1%), it is associated with inferior outcome to tyrosine kinase inhibitors.
The most common BCR-ABL transcripts in chronic myeloid leukemia (CML) are e13a2(b2a2)... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2815754</comments>
            <pubDate>Tue, 22 Sep 2009 16:16:18 +0100</pubDate>
            <guid isPermaLink="false">2815754</guid>        </item>
        <item>
            <title>Preirradiation Sinus Mucosal Disease in Patients With Nasopharyngeal Carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=2798022&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FPreirradiation_Sinus_Mucosal_Disease_in_Patients_With_Nasopharyngeal_Carcinoma.html</link>
            <description>The objective of this study was to evaluate the incidence and the possible... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2798022</comments>
            <pubDate>Wed, 16 Sep 2009 16:13:10 +0100</pubDate>
            <guid isPermaLink="false">2798022</guid>        </item>
        <item>
            <title>Long-Term Outcome of Patients With Chronic Myeloid Leukemia Treated With Second-Generation Tyrosine Kinase Inhibitors</title>
            <link>http://www.medworm.com/index.php?rid=2794274&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FLong_Term_Outcome_of_Patients_With_Chronic_Myeloid_Leukemia_Treated_With_Second_Generation_Tyrosine_Kinase_Inhibitors.html</link>
            <description>For patients in chronic-phase CML who were treated with second generation tyrosine inhibitors after failure with imatinib, hematologic and cytogenetic response rates correlated with BCR-ABL mutation score...
Secondary... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2794274</comments>
            <pubDate>Tue, 15 Sep 2009 16:14:39 +0100</pubDate>
            <guid isPermaLink="false">2794274</guid>        </item>
        <item>
            <title>Prospective Comparison of Surgery Alone and Chemoradiotherapy With Selective Surgery in Resectable Squamous Cell Carcinoma of the Esophagus</title>
            <link>http://www.medworm.com/index.php?rid=2794273&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FProspective_Comparison_of_Surgery_Alone_and_Chemoradiotherapy_With_Selective_Surgery_in_Resectable_Squamous_Cell_Carcinoma_of_the_Esophagus.html</link>
            <description>Comparison of CRT and surgery for resectable esophageal squamous cell carcinoma showed comparable outcomes.
Purpose. Esophagectomy remains the mainstay treatment for esophageal cancer, although retrospective... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2794273</comments>
            <pubDate>Tue, 15 Sep 2009 16:14:39 +0100</pubDate>
            <guid isPermaLink="false">2794273</guid>        </item>
        <item>
            <title>Application of Robotic Stereotactic Radiotherapy to Peripheral Stage I Non-Small Cell Lung Cancer With Curative Intent</title>
            <link>http://www.medworm.com/index.php?rid=2794272&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FApplication_of_Robotic_Stereotactic_Radiotherapy_to_Peripheral_Stage_I_Non_Small_Cell_Lung_Cancer_With_Curative_Intent.html</link>
            <description>Robotic stereotactic radiotherapy was safe and superior to conventionally fractionated radiotherapy for stage I peripheral NSCLC.
Aims. To determine the effectiveness of robotic stereotactic radiotherapy... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2794272</comments>
            <pubDate>Tue, 15 Sep 2009 16:14:39 +0100</pubDate>
            <guid isPermaLink="false">2794272</guid>        </item>
        <item>
            <title>Tamoxifen Reduces the Risk of Contralateral Breast Cancer in Premenopausal Women</title>
            <link>http://www.medworm.com/index.php?rid=2791046&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FTamoxifen_Reduces_the_Risk_of_Contralateral_Breast_Cancer_in_Premenopausal_Women.html</link>
            <description>Adjuvant tamoxifen for 2 years reduced the incidence of contralateral breast cancer by 50% in premenopausal women.
Background. Adjuvant treatment with tamoxifen reduces the risk of contralateral breast... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2791046</comments>
            <pubDate>Mon, 14 Sep 2009 16:14:34 +0100</pubDate>
            <guid isPermaLink="false">2791046</guid>        </item>
        <item>
            <title>F18-Fluorodeoxyglucose Positron Emission Tomography in the Context of Other Imaging Techniques and Prognostic Factors in Multiple Myeloma</title>
            <link>http://www.medworm.com/index.php?rid=2791045&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FF18_Fluorodeoxyglucose_Positron_Emission_Tomography_in_the_Context_of_Other_Imaging_Techniques_and_Prognostic_Factors_in_Multiple_Myeloma.html</link>
            <description>Serial PET exams may aid in individualizing therapy, as FDG suppression before first transplant confers superior outcomes.
F18-fluorodeoxyglucose positron emission tomography (FDG-PET) is a powerful tool... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2791045</comments>
            <pubDate>Mon, 14 Sep 2009 16:14:34 +0100</pubDate>
            <guid isPermaLink="false">2791045</guid>        </item>
        <item>
            <title>Maximum vs. Mono Androgen Blockade and the Risk of Recurrence in Men With Localized Prostate Cancer Undergoing Brachytherapy</title>
            <link>http://www.medworm.com/index.php?rid=2776083&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FMaximum_vs_Mono_Androgen_Blockade_and_the_Risk_of_Recurrence_in_Men_With_Localized_Prostate_Cancer_Undergoing_Brachytherapy.html</link>
            <description>We examined whether maximum androgen blockade (MAB) is associated with a decreased... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2776083</comments>
            <pubDate>Wed, 09 Sep 2009 16:13:54 +0100</pubDate>
            <guid isPermaLink="false">2776083</guid>        </item>
        <item>
            <title>Radiation Dose Predicts for Biochemical Control in Intermediate-Risk Prostate Cancer Patients Treated With Low-Dose-Rate Brachytherapy</title>
            <link>http://www.medworm.com/index.php?rid=2776082&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FRadiation_Dose_Predicts_for_Biochemical_Control_in_Intermediate_Risk_Prostate_Cancer_Patients_Treated_With_Low_Dose_Rate_Brachytherapy.html</link>
            <description>Prostate brachytherapy seed implant alone, implant with hormone therapy, and trimodality therapy (implant + hormones + EBRT) were equally effective treatment for intermediate-risk prostate cancer. Radiation...
Purpose.... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2776082</comments>
            <pubDate>Wed, 09 Sep 2009 16:13:54 +0100</pubDate>
            <guid isPermaLink="false">2776082</guid>        </item>
        <item>
            <title>Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=2776081&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FInhibition_of_the_Hedgehog_Pathway_in_Advanced_Basal_Cell_Carcinoma.html</link>
            <description>In a phase I trial of 33 patients with advanced basal cell carcinoma treated with GDC-0449, an inhibitor of the hedgehog signaling pathway, 18 patients responded (2 CRs, 16 PRs) and 11 patients had stable...
Background:... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2776081</comments>
            <pubDate>Wed, 09 Sep 2009 16:13:54 +0100</pubDate>
            <guid isPermaLink="false">2776081</guid>        </item>
        <item>
            <title>Disparities in Gastric Cancer Outcomes Among Asian Ethnicities in the USA</title>
            <link>http://www.medworm.com/index.php?rid=2773281&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FDisparities_in_Gastric_Cancer_Outcomes_Among_Asian_Ethnicities_in_the_USA.html</link>
            <description>Asian patients of differing ethnic backgrounds who have gastric cancer exhibit disparate clinical and pathologic features.
Related Links:
Access this article »
... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2773281</comments>
            <pubDate>Tue, 08 Sep 2009 16:15:15 +0100</pubDate>
            <guid isPermaLink="false">2773281</guid>        </item>
        <item>
            <title>Prognostic Value of Vascular Endothelial Growth Factor Expression in Patients With Lung Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2773280&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FPrognostic_Value_of_Vascular_Endothelial_Growth_Factor_Expression_in_Patients_With_Lung_Cancer.html</link>
            <description>VEGF overexpression indicates a poor prognosis for patients with NSCLC and SCLC.
Background. Vascular endothelial growth factor (VEGF) has been implicated in tumorigenesis and metastasis, and it presumably... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2773280</comments>
            <pubDate>Tue, 08 Sep 2009 16:15:15 +0100</pubDate>
            <guid isPermaLink="false">2773280</guid>        </item>
        <item>
            <title>Complete Soft-Tissue Sarcoma Resection Is a Viable Treatment Option for Select Elderly Patients</title>
            <link>http://www.medworm.com/index.php?rid=2763453&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FComplete_Soft_Tissue_Sarcoma_Resection_Is_a_Viable_Treatment_Option_for_Select_Elderly_Patients.html</link>
            <description>Properly selected elderly patients can safely undergo extensive resection of soft-tissue sarcomas.
Background. Decreased performance status, comorbidities, and disease natural history may erode enthusiasm... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2763453</comments>
            <pubDate>Fri, 04 Sep 2009 16:16:03 +0100</pubDate>
            <guid isPermaLink="false">2763453</guid>        </item>
        <item>
            <title>Outcome of Locally Recurrent and Metastatic Angiosarcoma</title>
            <link>http://www.medworm.com/index.php?rid=2748625&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FOutcome_of_Locally_Recurrent_and_Metastatic_Angiosarcoma.html</link>
            <description>Locally recurrent AS is treatable, but outlook for metastatic AS is favorable only with isolated lymphatic spread and taxol treatment.
Background. Angiosarcoma (AS) is a rare soft tissue sarcoma with... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2748625</comments>
            <pubDate>Tue, 01 Sep 2009 11:44:34 +0100</pubDate>
            <guid isPermaLink="false">2748625</guid>        </item>
        <item>
            <title>Complete Soft Tissue Sarcoma Resection Is a Viable Treatment Option for Select Elderly Patients</title>
            <link>http://www.medworm.com/index.php?rid=2748624&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FComplete_Soft_Tissue_Sarcoma_Resection_Is_a_Viable_Treatment_Option_for_Select_Elderly_Patients.html</link>
            <description>Properly selected elderly patients can safely undergo extensive resection of soft tissue sarcomas.
Background. Decreased performance status, comorbidities, and disease natural history may erode enthusiasm... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2748624</comments>
            <pubDate>Tue, 01 Sep 2009 11:44:34 +0100</pubDate>
            <guid isPermaLink="false">2748624</guid>        </item>
        <item>
            <title>Survival Without Toxicity for Cisplatin Plus Pemetrexed Versus Cisplatin Plus Gemcitabine in Chemonaïve Patients With Advanced Non-Small Cell Lung Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2748623&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FSurvival_Without_Toxicity_for_Cisplatin_Plus_Pemetrexed_Versus_Cisplatin_Plus_Gemcitabine.html</link>
            <description>Platinum-based chemotherapy doublets have comparable efficacy when used to treat newly diagnosed non-small cell lung cancer (NSCLC). Therefore, toxicity is an important factor when making treatment decisions...
Background.... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2748623</comments>
            <pubDate>Tue, 01 Sep 2009 11:44:34 +0100</pubDate>
            <guid isPermaLink="false">2748623</guid>        </item>
        <item>
            <title>Clinical Significance of Axillary Microresiduals After Neoadjuvant Chemotherapy in Breast Cancer Patients with Cytologically Proven Metastases</title>
            <link>http://www.medworm.com/index.php?rid=2748622&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FClinical_Significance_of_Axillary_Microresiduals_After_Neoadjuvant_Chemotherapy_in_Breast_Cancer_Patients_with_Cytologically_Proven_Metastases.html</link>
            <description>Axillary lymph node metastasis &gt;0.2 mm are clinically significant after neoadjuvant therapy for metastatic breast cancer. Multislice screening is warranted for patients with ALN metastases (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2748622</comments>
            <pubDate>Tue, 01 Sep 2009 11:44:34 +0100</pubDate>
            <guid isPermaLink="false">2748622</guid>        </item>
        <item>
            <title>Mean Cell Volume Can Be an Early Predictor for the Cytogenetic Response of Chronic Myeloid Leukemia Patients Treated With Imatinib</title>
            <link>http://www.medworm.com/index.php?rid=2748621&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FMean_Cell_Volume_Can_Be_an_Early_Predictor_for_the_Cytogenetic_Response_of_Chronic_Myeloid_Leukemia_Patients_Treated_With_Imatinib.html</link>
            <description>In this small retrospective study of 84 patients with CML who were treated with imatinib, mean cell volume (MCV) was found to be an independent predictor of cytogenetic response. An early, continued increase...
Imatinib-induced... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2748621</comments>
            <pubDate>Tue, 01 Sep 2009 11:44:34 +0100</pubDate>
            <guid isPermaLink="false">2748621</guid>        </item>
        <item>
            <title>Primary and Locally Recurrent Retroperitoneal Soft-Tissue Sarcoma: Local Control and Survival</title>
            <link>http://www.medworm.com/index.php?rid=2727933&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FPrimary_and_Locally_Recurrent_Retroperitoneal_Soft_Tissue_Sarcoma_Local_Control_and_Survival.html</link>
            <description>This study comparing management of primary and recurrent retroperitoneal soft-tissue sarcomas showed the feasibility of repeat surgery. Survival was comparable for primary and locally recurrent tumors...
Aim.... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2727933</comments>
            <pubDate>Tue, 25 Aug 2009 11:46:01 +0100</pubDate>
            <guid isPermaLink="false">2727933</guid>        </item>
        <item>
            <title>Cytoreductive Surgery and Intraperitoneal Chemotherapy for Peritoneal Mesothelioma</title>
            <link>http://www.medworm.com/index.php?rid=2727932&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FCytoreductive_Surgery_and_Intraperitoneal_Chemotherapy_for_Peritoneal_Mesothelioma.html</link>
            <description>Combining introperitoneal chemotherapy with cytoreduction yielded longer survival (3.7 years) than with palliative debulking (1 year).
Aims. Peritoneal mesothelioma is a rare disease and traditionally... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2727932</comments>
            <pubDate>Tue, 25 Aug 2009 11:46:01 +0100</pubDate>
            <guid isPermaLink="false">2727932</guid>        </item>
        <item>
            <title>Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma</title>
            <link>http://www.medworm.com/index.php?rid=2721363&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FGefitinib_or_Carboplatin_Paclitaxel_in_Pulmonary_Adenocarcinoma.html</link>
            <description>Asian study shows gefitinib is superior to carboplatin–paclitaxel as initial therapy for adenocarcinoma, especially if EGFR mutation is present.
BACKGROUND. Previous, uncontrolled studies have suggested... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2721363</comments>
            <pubDate>Sat, 22 Aug 2009 10:03:35 +0100</pubDate>
            <guid isPermaLink="false">2721363</guid>        </item>
        <item>
            <title>Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2721362&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FScreening_for_Epidermal_Growth_Factor_Receptor_Mutations_in_Lung_Cancer.html</link>
            <description>Screening for EGFR mutations in women, neversmokers, and patients with adenocarcinoma may improve outcomes in erlotinib-treated lung cancer.
Background. Activating mutations in the epidermal growth factor... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2721362</comments>
            <pubDate>Sat, 22 Aug 2009 10:03:35 +0100</pubDate>
            <guid isPermaLink="false">2721362</guid>        </item>
        <item>
            <title>Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2721361&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FLetrozole_Therapy_Alone_or_in_Sequence_with_Tamoxifen_in_Women_with_Breast_Cancer.html</link>
            <description>Sequential treatment with letrozole and tamoxifen, vs letrozole alone, did not improve DFS among postmenopausal women.
Background. The aromatase inhibitor letrozole, as compared with tamoxifen, improves... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2721361</comments>
            <pubDate>Sat, 22 Aug 2009 10:03:35 +0100</pubDate>
            <guid isPermaLink="false">2721361</guid>        </item>
        <item>
            <title>Follicular Lymphoma International Prognostic Index 2</title>
            <link>http://www.medworm.com/index.php?rid=2700703&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FFollicular_Lymphoma_International_Prognostic_Index_2.html</link>
            <description>FLIPI2 is a promising new prognostic index in the current era of immunochemotherapy. FLIPI2 is simple and based on easily accessed clinical information.
Access this article »
... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2700703</comments>
            <pubDate>Sat, 15 Aug 2009 10:03:22 +0100</pubDate>
            <guid isPermaLink="false">2700703</guid>        </item>
        <item>
            <title>Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia</title>
            <link>http://www.medworm.com/index.php?rid=2700702&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FPhase_III_Randomized_Study_of_Bendamustine_Compared_With_Chlorambucil_in_Previously_Untreated_Patients_With_Chronic_Lymphocytic_Leukemia.html</link>
            <description>This pivotal phase III study showed that bendamustine provides significantly greater efficacy than chlorambucil when used as first-line therapy in patients with advanced CLL. Toxicity with bendamustine...
Access... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2700702</comments>
            <pubDate>Sat, 15 Aug 2009 10:03:22 +0100</pubDate>
            <guid isPermaLink="false">2700702</guid>        </item>
        <item>
            <title>Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2700701&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FDenosumab_in_Men_Receiving_Androgen_Deprivation_Therapy_for_Prostate_Cancer.html</link>
            <description>After 24 months of therapy, denosumab was associated with increased bone mineral density in the lumbar spine, femoral neck, and total hip and reduced the incidence of new vertebral fractures in men receiving...
Background.... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2700701</comments>
            <pubDate>Sat, 15 Aug 2009 10:03:22 +0100</pubDate>
            <guid isPermaLink="false">2700701</guid>        </item>
        <item>
            <title>Micrometastases or Isolated Tumor Cells and the Outcome of Breast Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2700700&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FMicrometastases_or_Isolated_Tumor_Cells_and_the_Outcome_of_Breast_Cancer.html</link>
            <description>The presence of isolated tumor cells or micrometastases in sentinel or axillary lymph nodes was associated with reduced 5-year DFS among women with early-stage breast cancer. Use of adjuvant therapy in...
Background:... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2700700</comments>
            <pubDate>Sat, 15 Aug 2009 10:03:22 +0100</pubDate>
            <guid isPermaLink="false">2700700</guid>        </item>
        <item>
            <title>TET2 Mutation Is an Independent Favorable Prognostic Factor in Myelodysplastic Syndromes (MDS)</title>
            <link>http://www.medworm.com/index.php?rid=2700699&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FTET2_Mutation_Is_an_Independent_Favorable_Prognostic_Factor_in_Myelodysplastic_Syndromes_MDS.html</link>
            <description>Among patients with Myelodysplastic Syndromes, the presence of TET2 mutations (~20% of patients) indicate good prognosis, including better 5-year survival and 3-year leukemia-free survival.
Oncogenic... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2700699</comments>
            <pubDate>Sat, 15 Aug 2009 10:03:22 +0100</pubDate>
            <guid isPermaLink="false">2700699</guid>        </item>
        <item>
            <title>Patterns and Risk Factors Associated With Aromatase Inhibitor-Related Arthralgia Among Breast Cancer Survivors</title>
            <link>http://www.medworm.com/index.php?rid=2700698&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FPatterns_and_Risk_Factors_Associated_With_Aromatase_Inhibitor_Related_Arthralgia_Among_Breast_Cancer_Survivors.html</link>
            <description>Arthralgia began within 3 months of AI therapy and was most common when the last menstrual period occurred within 5 years. AI-associated arthralgia may be related to estrogen withdrawal.
BACKGROUND: Arthralgia... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2700698</comments>
            <pubDate>Sat, 15 Aug 2009 10:03:22 +0100</pubDate>
            <guid isPermaLink="false">2700698</guid>        </item>
        <item>
            <title>Efficacy Comparison Between 18F-FDG PET/CT and Bone Scintigraphy in Detecting Bony Metastases of Non-Small-Cell Lung Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2700697&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FEfficacy_Comparison_Between_18F_FDG_PET_CT_and_Bone_Scintigraphy_in_Detecting_Bony_Metastases_of_Non_Small_Cell_Lung_Cancer.html</link>
            <description>PET/CT was superior to bone scan in detecting bone metastases from NSCLC, yielding fewer false-positives and false-negatives.
Background: We compared the efficacies of integrated whole-body 18F-FDG PET/CT... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2700697</comments>
            <pubDate>Sat, 15 Aug 2009 10:03:22 +0100</pubDate>
            <guid isPermaLink="false">2700697</guid>        </item>
        <item>
            <title>Prognostic Value of KRAS Mutations and Ki-67 Expression in Stage I Lung Adenocarcinomas</title>
            <link>http://www.medworm.com/index.php?rid=2700696&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FPrognostic_Value_of_KRAS_Mutations_and_Ki_67_Expression_in_Stage_I_Lung_Adenocarcinomas.html</link>
            <description>KRAS mutations and Ki-67 overexpression, and, especially, both together, predicted a higher risk of recurrence of stage I lung adenocarcinoma.
The purpose of the present study was to establish accurate... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2700696</comments>
            <pubDate>Sat, 15 Aug 2009 10:03:22 +0100</pubDate>
            <guid isPermaLink="false">2700696</guid>        </item>
        <item>
            <title>Late Outcomes Following Hypofractionated Conformal Radiotherapy vs. Standard Fractionation for Localized Prostate Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2689508&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FLate_Outcomes_Following_Hypofractionated_Conformal_Radiotherapy_vs_Standard_Fractionation_for_Localized_Prostate_Cancer.html</link>
            <description>Comparison of patients with prostate cancer who were treated with either hypofractionation (20 RT fractions in 5 weeks) or standard fractionation showed that biochemical control was not compromised. Late...
Purpose:... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2689508</comments>
            <pubDate>Wed, 12 Aug 2009 10:03:35 +0100</pubDate>
            <guid isPermaLink="false">2689508</guid>        </item>
        <item>
            <title>Metabolic Tumor Volume Predicts for Recurrence and Death in Head-and-Neck Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2679701&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FMetabolic_Tumor_Volume_Predicts_for_Recurrence_and_Death_in_Head_and_Neck_Cancer.html</link>
            <description>As a direct measure of tumor burden, metabolic tumor volume is an adverse prognostic indicator of disease recurrence and death in head and neck cancer.
Purpose: To evaluate the prognostic value of metabolic... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2679701</comments>
            <pubDate>Sat, 08 Aug 2009 10:37:53 +0100</pubDate>
            <guid isPermaLink="false">2679701</guid>        </item>
        <item>
            <title>Efficacy of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration of Hilar Lymph Nodes for Diagnosing and Staging Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2679700&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FEfficacy_of_Endobronchial_Ultrasound_Guided_Transbronchial_Needle_Aspiration_of_Hilar_Lymph_Nodes_for_Diagnosing_and_Staging_Cancer.html</link>
            <description>EBUS-TBNA, performed by experienced operators in this study, identified malignant hilar lymph nodes (CT visible or PET-scan positive) with the same accuracy as for central mediastinal nodes. Sensitivity...
Introduction:... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2679700</comments>
            <pubDate>Sat, 08 Aug 2009 10:37:53 +0100</pubDate>
            <guid isPermaLink="false">2679700</guid>        </item>
        <item>
            <title>Determining the Rise in BCR-ABL RNA That Optimally Predicts a Kinase Domain Mutation in Patients With Chronic Myeloid Leukemia on Imatinib</title>
            <link>http://www.medworm.com/index.php?rid=2668756&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FDetermining_the_Rise_in_BCR_ABL_RNA_That_Optimally_Predicts_a_Kinase_Domain_Mutation_in_Patients_With_Chronic_Myeloid_Leukemia_on_Imatinib.html</link>
            <description>Patients with a 2.6-fold or greater increase in BCR-ABL RNA transcript levels by RQ-PCR should be screened for kinase-domain mutations associated with imatinib resistance.
In imatinib-treated CML, secondary... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2668756</comments>
            <pubDate>Wed, 05 Aug 2009 10:37:30 +0100</pubDate>
            <guid isPermaLink="false">2668756</guid>        </item>
        <item>
            <title>Image-Guided Intensity-Modulated Radiotherapy for Biliary Adenocarcinomas</title>
            <link>http://www.medworm.com/index.php?rid=2668755&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FImage_Guided_Intensity_Modulated_Radiotherapy_for_Biliary_Adenocarcinomas.html</link>
            <description>Image-guided intensity-modulated RT appears to be feasible for patients with biliary tract tumors. Median survival was nearly double that in the group treated with conventional RT, but about half of the...
Purpose:... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2668755</comments>
            <pubDate>Wed, 05 Aug 2009 10:37:30 +0100</pubDate>
            <guid isPermaLink="false">2668755</guid>        </item>
        <item>
            <title>Survival After Radiotherapy in Gastric Cancer: Systematic Review and Meta-analysis</title>
            <link>http://www.medworm.com/index.php?rid=2668754&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FSurvival_After_Radiotherapy_in_Gastric_Cancer_Systematic_Review_and_Meta_analysis.html</link>
            <description>Results of this meta-analysis may dispel some of the controversy regarding the role of RT in gastric cancer. Five-year survival was consistently superior with regimens including RT, as compared with surgery...
Background... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2668754</comments>
            <pubDate>Wed, 05 Aug 2009 10:37:30 +0100</pubDate>
            <guid isPermaLink="false">2668754</guid>        </item>
        <item>
            <title>Survivin Expression as a Predictive Marker for Local Control in Patients With High-Risk T1 Bladder Cancer Treated With Transurethral Resection and Radiochemotherapy</title>
            <link>http://www.medworm.com/index.php?rid=2668753&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FSurvivin_Expression_as_a_Predictive_Marker_for_Local_Control_in_Patients_With_High_Risk_T1_Bladder_Cancer_Treated_With_Transurethral_Resection_and_Radiochemotherapy.html</link>
            <description>Survivin was overexpressed in 67% of T1 tumors. Overexpression did not correlate with clinicopathologic features, but it was associated with a higher risk for recurrence in patients treated with TURBT...
Purpose:... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2668753</comments>
            <pubDate>Wed, 05 Aug 2009 10:37:30 +0100</pubDate>
            <guid isPermaLink="false">2668753</guid>        </item>
        <item>
            <title>Higher-Than-Conventional Radiation Doses in Localized Prostate Cancer Treatment: A Meta-analysis of Randomized, Controlled Trials</title>
            <link>http://www.medworm.com/index.php?rid=2668752&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FHigher_Than_Conventional_Radiation_Doses_in_Localized_Prostate_Cancer_Treatment_A_Meta-analysis_of_Randomized_Controlled_Trials.html</link>
            <description>Meta-analysis showed that high-dose RT was superior to conventional-dose RT in reducing biochemical failure in patients with localized prostate cancer. Patients at all risk levels received benefit. The...
Purpose:... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2668752</comments>
            <pubDate>Wed, 05 Aug 2009 10:37:30 +0100</pubDate>
            <guid isPermaLink="false">2668752</guid>        </item>
        <item>
            <title>Inflammation-Associated Biomarkers Predict Breast Cancer Survival</title>
            <link>http://www.medworm.com/index.php?rid=2650855&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FInflammation_Associated_Biomarkers_Predict_Breast_Cancer_Survival.html</link>
            <description>Biomarkers associated with inflammation, C-reactive protein and serum amyloid A, are independent prognostic markers for breast cancer survival.
Access this article »
... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2650855</comments>
            <pubDate>Thu, 30 Jul 2009 10:37:46 +0100</pubDate>
            <guid isPermaLink="false">2650855</guid>        </item>
        <item>
            <title>Evaluating More Lymph Nodes May Not Improve Identification of Late-Stage Colorectal Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2650854&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FEvaluating_More_Lymph_Nodes_May_Not_Improve_Identification_of_Late_Stage_Colorectal_Cancer.html</link>
            <description>This single-center study required that a minimum of 12 nodes be excised and examined during resection for colorectal cancer. However, this increased lymph node yield did not identify an increased number...
Access... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2650854</comments>
            <pubDate>Thu, 30 Jul 2009 10:37:46 +0100</pubDate>
            <guid isPermaLink="false">2650854</guid>        </item>
        <item>
            <title>Safety and Efficacy of Sunitinib for Metastatic Renal-Cell Carcinoma: An Expanded-Access Trial</title>
            <link>http://www.medworm.com/index.php?rid=2646668&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FSafety_and_Efficacy_of_Sunitinib_for_Metastatic_Renal_Cell_Carcinoma_An_Expanded_Access_Trial.html</link>
            <description>Sunitinib was studied on a compassionate-use basis in RCC patients ineligible for clinical trials. Responses occurred in patients with brain metastases (12%), PS &gt;2 (9%), and older age (17%). Treatment-related...
Background.... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2646668</comments>
            <pubDate>Wed, 29 Jul 2009 10:38:14 +0100</pubDate>
            <guid isPermaLink="false">2646668</guid>        </item>
        <item>
            <title>First Line Therapy With Fludarabine Compared to Chlorambucil Does Not Result in a Major Benefit for Elderly Patients With Advanced Chronic Lymphocytic Leukemia</title>
            <link>http://www.medworm.com/index.php?rid=2642071&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FFirst_Line_Therapy_With_Fludarabine_Compared_to_Chlorambucil_Does_Not_Result_in_a_Major_Benefit_for_Elderly_Patients_With_Advanced_Chronic_Lymphocytic_Leukemia.html</link>
            <description>While CLL is a disease of elderly patients, subjects older than 65 years are heavily underrepresented in clinical trials. The German CLL study group (GCLLSG) initiated a multicentre phase III trial for... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2642071</comments>
            <pubDate>Tue, 28 Jul 2009 10:37:58 +0100</pubDate>
            <guid isPermaLink="false">2642071</guid>        </item>
        <item>
            <title>Fractionated Stereotactic Radiotherapy as Reirradiation for Locally Recurrent Head and Neck Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2642070&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FFractionated_Stereotactic_Radiotherapy_as_Reirradiation_for_Locally_Recurrent_Head_and_Neck_Cancer.html</link>
            <description>Fractionated stereotactic radiosurgery induced complete response in 15 of 35 sites. It provided effective short-term, local control, but longer follow-up is needed to characterize late complications.
Purpose.... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2642070</comments>
            <pubDate>Tue, 28 Jul 2009 10:37:58 +0100</pubDate>
            <guid isPermaLink="false">2642070</guid>        </item>
        <item>
            <title>Risk of Death From Prostate Cancer After Brachytherapy Alone or With Radiation, Androgen Suppression Therapy, or Both in Men With High-Risk Disease</title>
            <link>http://www.medworm.com/index.php?rid=2635540&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FRisk_of_Death_From_Prostate_Cancer_After_Brachytherapy_Alone_or_With_Radiation_Androgen_Suppression_Therapy_or_Both_in_Men_With_High_Risk_Disease.html</link>
            <description>Brachytherapy with ADT and RT decreases the risk of prostate cancer–specific mortality in men with high-risk disease.
Access this article »
... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2635540</comments>
            <pubDate>Sat, 25 Jul 2009 10:38:07 +0100</pubDate>
            <guid isPermaLink="false">2635540</guid>        </item>
        <item>
            <title>Hormone Therapy and Ovarian Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2635539&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FHormone_Therapy_and_Ovarian_Cancer.html</link>
            <description>This nationwide Danish prospective cohort study showed that hormone therapy is associated with an increased risk of ovarian cancer, regardless of the duration, dose, or formulation of treatment.
Access... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2635539</comments>
            <pubDate>Sat, 25 Jul 2009 10:38:07 +0100</pubDate>
            <guid isPermaLink="false">2635539</guid>        </item>
        <item>
            <title>Capsule Endoscopy versus Colonoscopy</title>
            <link>http://www.medworm.com/index.php?rid=2635538&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FCapsule_Endoscopy_versus_Colonoscopy.html</link>
            <description>CTC and OC have similar rates for neoplasm detection, but CTC was associated with fewer polypectomies and complications.
Background: Advanced neoplasia represents the primary target for colorectal-cancer... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2635538</comments>
            <pubDate>Sat, 25 Jul 2009 10:38:07 +0100</pubDate>
            <guid isPermaLink="false">2635538</guid>        </item>
        <item>
            <title>Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial</title>
            <link>http://www.medworm.com/index.php?rid=2627722&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FSorafenib_for_Treatment_of_Renal_Cell_Carcinoma_Final_Efficacy_and_Safety_Results_of_the_Phase_III_Treatment_Approaches_in_Renal_Cancer_Global_Evaluation_Trial.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
Results of TARGET indicate that, after censoring the cross-over group, sorafenib significantly improved in patients with advanced RCC.
STUDY... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2627722</comments>
            <pubDate>Thu, 23 Jul 2009 10:37:55 +0100</pubDate>
            <guid isPermaLink="false">2627722</guid>        </item>
        <item>
            <title>Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma</title>
            <link>http://www.medworm.com/index.php?rid=2617477&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FPhase_III_Study_to_Evaluate_Temsirolimus_Compared_With_Investigators_Choice_Therapy_for_the_Treatment_of_Relapsed_or_Refractory_Mantle_Cell_Lymphoma.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
Temsirolimus in refractory or relapsed MCL provides a significant benefit in PFS and ORR in heavily pretreated patients.
STUDY IN CONTEXT
Of... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2617477</comments>
            <pubDate>Tue, 21 Jul 2009 10:37:54 +0100</pubDate>
            <guid isPermaLink="false">2617477</guid>        </item>
        <item>
            <title>Hypofractionated and Accelerated Radiotherapy With Subcutaneous Amifostine Cytoprotection as Short Adjuvant Regimen After Breast-Conserving Surgery</title>
            <link>http://www.medworm.com/index.php?rid=2617476&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FHypofractionated_and_Accelerated_Radiotherapy_With_Subcutaneous_Amifostine_Cytoprotection_as_Short_Adjuvant_Regimen_After_Breast_Conserving_Surgery_Interim_Report.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
Hypofractionated and highly accelerated RT/amifostine showed encouraging efficacy (3.3% in-field relapse). High-dose amifostine (1,000... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2617476</comments>
            <pubDate>Tue, 21 Jul 2009 10:37:54 +0100</pubDate>
            <guid isPermaLink="false">2617476</guid>        </item>
        <item>
            <title>Estimating the Prevalence of Myelodysplastic Syndromes in Patients With Unexplained Cytopenias: A Retrospective Study of 322 Bone Marrows</title>
            <link>http://www.medworm.com/index.php?rid=2617475&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FEstimating_the_Prevalence_of_Myelodysplastic_Syndromes_in_Patients_With_Unexplained_Cytopenias_A_Retrospective_Study_of_322_Bone_Marrows.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
In community-based individuals referred for unexplained anemia or cytopenia, bone marrow examination confirmed MDS in 22.6%, and in... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2617475</comments>
            <pubDate>Tue, 21 Jul 2009 10:37:54 +0100</pubDate>
            <guid isPermaLink="false">2617475</guid>        </item>
        <item>
            <title>Duration of Chemotherapy for Advanced Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Trials</title>
            <link>http://www.medworm.com/index.php?rid=2612132&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FDuration_of_Chemotherapy_for_Advanced_Non_Small_Cell_Lung_Cancer_A_Systematic_Review_and_Meta_Analysis_of_Randomized_Trials.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
Meta-analysis showed that continuing chemotherapy beyond a standard number of cycles resulted in significantly prolonged PFS, especially... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2612132</comments>
            <pubDate>Sat, 18 Jul 2009 10:36:37 +0100</pubDate>
            <guid isPermaLink="false">2612132</guid>        </item>
        <item>
            <title>Long-Term Outcomes and Toxicity of Concurrent Paclitaxel and Radiotherapy for Locally Advanced Head-and-Neck Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2612131&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FLong_Term_Outcomes_and_Toxicity_of_Concurrent_Paclitaxel_and_Radiotherapy_for_Locally_Advanced_Head_and_Neck_Cancer.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
Late toxicities and functional impairment were the focus of this study of patients treated with chemoradiotherapy using paclitaxel.... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2612131</comments>
            <pubDate>Sat, 18 Jul 2009 10:36:37 +0100</pubDate>
            <guid isPermaLink="false">2612131</guid>        </item>
        <item>
            <title>Outcome of T1N0M0 Squamous Cell Carcinoma of the Larynx Treated With Short-Course Radiotherapy to a Total Dose of 50 Gy in 16 Fractions</title>
            <link>http://www.medworm.com/index.php?rid=2612130&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FOutcome_of_T1N0M0_Squamous_Cell_Carcinoma_of_the_Larynx_Treated_With_Short_Course_Radiotherapy_to_a_Total_Dose_of_50_Gy_in_16_Fractions.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
Radiotherapy to a total dose of 50 Gy in 16 fractions achieved locoregional control and voice preservation comparable to results attained... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2612130</comments>
            <pubDate>Sat, 18 Jul 2009 10:36:37 +0100</pubDate>
            <guid isPermaLink="false">2612130</guid>        </item>
        <item>
            <title>A Risk Score to Predict Disease-Free Survival in Patients Not Achieving a Pathological Complete Remission After Preoperative Chemotherapy for Breast Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2595276&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FA_Risk_Score_to_Predict_Disease-Free_Survival_in_Patients_Not_Achieving_a_Pathological_Complete_Remission_After_Preoperative_Chemotherapy_for_Breast_Cancer.html</link>
            <description>This study developed a nomogram that predicts DFS in breast cancer patients who fail to achieve a pCR after preoperative chemotherapy.
STUDY... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2595276</comments>
            <pubDate>Tue, 14 Jul 2009 10:38:50 +0100</pubDate>
            <guid isPermaLink="false">2595276</guid>        </item>
        <item>
            <title>Molecular Stratification Model for Prognosis in Cytogenetically Normal Acute Myeloid Leukemia</title>
            <link>http://www.medworm.com/index.php?rid=2595275&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FMolecular_Stratification_Model_for_Prognosis_in_Cytogenetically_Normal_Acute_Myeloid_Leukemia.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
A model using 3 molecular markers, ERG, EVI1, and PRAME, can be used for risk stratification in patients with cytogenetically normal... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2595275</comments>
            <pubDate>Tue, 14 Jul 2009 10:38:50 +0100</pubDate>
            <guid isPermaLink="false">2595275</guid>        </item>
        <item>
            <title>Carcinoma of the upper urinary tract : Predictors of survival and competing causes of mortality</title>
            <link>http://www.medworm.com/index.php?rid=2589379&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FCarcinoma_of_the_upper_urinary_tract_Predictors_of_survival_and_competing_causes_of_mortality.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
Tumor stage and grade are the most important predictors of survival in upper urinary tract cancer.
STUDY IN CONTEXT
Carcinomas of... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2589379</comments>
            <pubDate>Sat, 11 Jul 2009 10:37:15 +0100</pubDate>
            <guid isPermaLink="false">2589379</guid>        </item>
        <item>
            <title>Radiotherapy Is Associated With Improved Survival in Adjuvant and Palliative Treatment of Extrahepatic Cholangiocarcinomas</title>
            <link>http://www.medworm.com/index.php?rid=2589378&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FRadiotherapy_Is_Associated_With_Improved_Survival_in_Adjuvant_and_Palliative_Treatment_of_Extrahepatic_Cholangiocarcinomas.html</link>
            <description>This study helped clarify the role of RT in treating patients with EHC, as the reduction in mortality was only 5% with surgery plus... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2589378</comments>
            <pubDate>Sat, 11 Jul 2009 10:37:15 +0100</pubDate>
            <guid isPermaLink="false">2589378</guid>        </item>
        <item>
            <title>Increased Risk of Stroke and Transient Ischemic Attack in 5-Year Survivors of Hodgkin Lymphoma</title>
            <link>http://www.medworm.com/index.php?rid=2581774&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FIncreased_Risk_of_Stroke_and_Transient_Ischemic_Attack_in_5_Year_Survivors_of_Hodgkin_Lymphoma.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
This retrospective study identified neck and chest radiotherapy, younger age at treatment, and hypertension as independent risk factors... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581774</comments>
            <pubDate>Thu, 09 Jul 2009 10:37:02 +0100</pubDate>
            <guid isPermaLink="false">2581774</guid>        </item>
        <item>
            <title>Global Lung Oncology Branch Trial 3 (GLOB3): Final Results of a Randomised Multinational Phase III Study</title>
            <link>http://www.medworm.com/index.php?rid=2574006&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FGlobal_Lung_Oncology_Branch_Trial_3_GLOB3_Final_Results_of_a_Randomised_Multinational_Phase_III_Study.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
Oral vinorelbine alternating with intravenous vinorelbine plus cisplatin was similar in efficacy and safety to docetaxel plus cisplatin... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2574006</comments>
            <pubDate>Tue, 07 Jul 2009 10:37:32 +0100</pubDate>
            <guid isPermaLink="false">2574006</guid>        </item>
        <item>
            <title>The International Association for the Study of Lung Cancer Staging Project: Prognostic Factors and Pathologic TNM Stage in Surgically Managed Non-small Cell Lung Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2574005&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FThe_International_Association_for_the_Study_of_Lung_Cancer_Staging_Project_Prognostic_Factors_and_Pathologic_TNM_Stage_in_Surgically_Managed_Non-small_Cell_Lung_Cancer.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
Results of the IASLC Staging Project show that in addition to TNM staging, age, gender, and histologic type are predictive for survival.... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2574005</comments>
            <pubDate>Tue, 07 Jul 2009 10:37:32 +0100</pubDate>
            <guid isPermaLink="false">2574005</guid>        </item>
        <item>
            <title>Soft Tissue Sarcomas of the Chest Wall</title>
            <link>http://www.medworm.com/index.php?rid=2574004&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FSoft_Tissue_Sarcomas_of_the_Chest_Wall.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
Chest wall soft tissue sarcomas exhibit similar behavior to those located in the extremities and are best controlled by wide surgical... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2574004</comments>
            <pubDate>Tue, 07 Jul 2009 10:37:32 +0100</pubDate>
            <guid isPermaLink="false">2574004</guid>        </item>
        <item>
            <title>Dasatinib early intervention after cytogenetic or hematologic resistance to imatinib in patients with chronic myeloid leukemia</title>
            <link>http://www.medworm.com/index.php?rid=2574003&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FDasatinib_early_intervention_after_cytogenetic_or_hematologic_resistance_to_imatinib_in_patients_with_chronic_myeloid_leukemia.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
Complete cytogenetic reponses were achieved in 72% of patients treated with dasatanib after loss of major cytogenetic response (MCyR)... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2574003</comments>
            <pubDate>Tue, 07 Jul 2009 10:37:32 +0100</pubDate>
            <guid isPermaLink="false">2574003</guid>        </item>
        <item>
            <title>Metastatic Renal Cell Carcinoma Risk According to Tumor Size</title>
            <link>http://www.medworm.com/index.php?rid=2574002&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FMetastatic_Renal_Cell_Carcinoma_Risk_According_to_Tumor_Size.html</link>
            <description>We present our experience with renal cell carcinoma. We evaluated... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2574002</comments>
            <pubDate>Tue, 07 Jul 2009 10:37:32 +0100</pubDate>
            <guid isPermaLink="false">2574002</guid>        </item>
        <item>
            <title>Preoperative Staging of Lung Cancer with Combined PET–CT</title>
            <link>http://www.medworm.com/index.php?rid=2574001&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FPreoperative_Staging_of_Lung_Cancer_with_Combined_PET_CT.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
Although PET–CT staging reduced both the total number of thoracotomies and the number of futile thoracotomies, there was no impact on... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2574001</comments>
            <pubDate>Tue, 07 Jul 2009 10:37:32 +0100</pubDate>
            <guid isPermaLink="false">2574001</guid>        </item>
        <item>
            <title>Hyperbaric Oxygen Therapy for Late Radiation-Associated Tissue Necroses: Is It Safe in Patients With Locoregionally Recurrent and Then Successfully Salvaged Head-and-Neck Cancers?</title>
            <link>http://www.medworm.com/index.php?rid=2574000&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FHyperbaric_Oxygen_Therapy_for_Late_Radiation_Associated_Tissue_Necroses_Is_It_Safe_in_Patients_With_Locoregionally_Recurrent_and_Then_Successfully_Salvaged_Head-and-Neck_Cancers.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
HBOT should be used cautiously as necrosis rescue in patients whose recurrent head and neck cancer was successfully salvaged. Patients... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2574000</comments>
            <pubDate>Tue, 07 Jul 2009 10:37:32 +0100</pubDate>
            <guid isPermaLink="false">2574000</guid>        </item>
        <item>
            <title>Phase 3 Study of Dasatinib 140 mg Once Daily Versus 70 mg Twice Daily in Patients With Chronic Myeloid Leukemia in Accelerated Phase Resistant or Intolerant to Imatinib: 15-Month Median Follow-up</title>
            <link>http://www.medworm.com/index.php?rid=2564073&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FPhase_3_Study_of_Dasatinib_140_mg_Once_Daily_Versus_70_mg_Twice_Daily_in_Patients_With_Chronic_Myeloid_Leukemia_in_Accelerated_Phase_Resistant_or_Intolerant_to_Imatinib.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
In patients with accelerated-phase chronic myeloid leukemia who are intolerant of or resistant to imatinib, once-daily dasatinib 140... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2564073</comments>
            <pubDate>Sun, 05 Jul 2009 10:37:50 +0100</pubDate>
            <guid isPermaLink="false">2564073</guid>        </item>
        <item>
            <title>Delayed Achievement of Cytogenetic and Molecular Response Is Associated With Increased Risk of Progression Among Patients With Chronic Myeloid Leukemia</title>
            <link>http://www.medworm.com/index.php?rid=2564072&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FDelayed_Achievement_of_Cytogenetic_and_Molecular_Response_Is_Associated_With_Increased_Risk_of_Progression_Among_Patients_With_Chronic_Myeloid_Leukemia.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
Patients not in CCyR after 12 months on imatinib have a higher risk of progression, which can be predicted at 3 months by molecular... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2564072</comments>
            <pubDate>Sun, 05 Jul 2009 10:37:50 +0100</pubDate>
            <guid isPermaLink="false">2564072</guid>        </item>
        <item>
            <title>Pesticide Exposure and Risk of Monoclonal Gammopathy of Undetermined Significance in the Agricultural Health Study</title>
            <link>http://www.medworm.com/index.php?rid=2564071&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FPesticide_Exposure_and_Risk_of_Monoclonal_Gammopathy_of_Undetermined_Significance_in_the_Agricultural_Health_Study.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
Increased risk of MGUS was found among men occupationally exposed to dieldrin (insecticide), carbon-tetrachloride plus carbon disulfide... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2564071</comments>
            <pubDate>Sun, 05 Jul 2009 10:37:50 +0100</pubDate>
            <guid isPermaLink="false">2564071</guid>        </item>
        <item>
            <title>Health-Related Quality of Life as a Survival Predictor for Patients With Localized Head and Neck Cancer Treated With Radiation Therapy</title>
            <link>http://www.medworm.com/index.php?rid=2564070&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FHealth_Related_Quality_of_Life_as_a_Survival_Predictor_for_Patients_With_Localized_Head_and_Neck_Cancer_Treated_With_Radiation_Therapy.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
Baseline physical functioning score and change in physical functioning significantly improved OS prediction over that of standard prognostic... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2564070</comments>
            <pubDate>Sun, 05 Jul 2009 10:37:50 +0100</pubDate>
            <guid isPermaLink="false">2564070</guid>        </item>
        <item>
            <title>Phase III Study of Dasatinib Once Daily for Imatinib-Resistant CML</title>
            <link>http://www.medworm.com/index.php?rid=2553838&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FPhase_III_Study_of_Dasatinib_Once_Daily_for_Imatinib_Resistant_CML.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
In patients with accelerated-phase chronic myeloid leukemia who are intolerant of or resistant to imatinib, once-daily dasatinib 140... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2553838</comments>
            <pubDate>Tue, 30 Jun 2009 14:58:25 +0100</pubDate>
            <guid isPermaLink="false">2553838</guid>        </item>
        <item>
            <title>Prognostic Factors in Adult Patients up to 60 Years Old With Acute Myeloid Leukemia and Translocations of Chromosome Band 11q23</title>
            <link>http://www.medworm.com/index.php?rid=2553837&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FPrognostic_Factors_in_Adult_Patients_up_to_60_Years_Old_With_Acute_Myeloid_Leukemia_and_Translocations_of_Chromosome_Band_11q23.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
Identification of the MLL fusion partner is critical for risk stratification in patients with t(11q23)-positive AML.
STUDY IN CONTEXT
Several... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2553837</comments>
            <pubDate>Tue, 30 Jun 2009 14:58:25 +0100</pubDate>
            <guid isPermaLink="false">2553837</guid>        </item>
        <item>
            <title>Inhibition of Poly(ADP-Ribose) Polymerase in Tumors From BRCA Mutation Carriers</title>
            <link>http://www.medworm.com/index.php?rid=2553836&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FInhibition_of_Poly_ADP_Ribose_Polymerase_in_Tumors_From_BRCA_Mutation_Carriers.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
Phase I results show olaparibis safe, rapidly absorbed, and has durable antitumor activity in confirmed carriers of BRCA1 or BRCA2 mutations.
STUDY... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2553836</comments>
            <pubDate>Tue, 30 Jun 2009 14:58:25 +0100</pubDate>
            <guid isPermaLink="false">2553836</guid>        </item>
        <item>
            <title>Chemotherapy in Head and Neck Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2553835&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FChemotherapy_in_Head_and_Neck_Cancer.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
Addition of 24 RCTs to a previous meta-analysis confirmed the benefit of concomitant, as opposed to induction, chemotherapy. The hazard... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2553835</comments>
            <pubDate>Tue, 30 Jun 2009 14:58:25 +0100</pubDate>
            <guid isPermaLink="false">2553835</guid>        </item>
        <item>
            <title>Randomized Phase II Trial of Chemoradiotherapy Followed by Either Dose-Dense or Metronomic Temozolomide for Newly Diagnosed Glioblastoma</title>
            <link>http://www.medworm.com/index.php?rid=2524183&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FRandomized_Phase_II_Trial_of_Chemoradiotherapy_Followed_by_Either_Dose-Dense_or_Metronomic_Temozolomide_for_Newly_Diagnosed_Glioblastoma.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
Dose-dense temozolomide in malignant gliomas, yielding an 80% 1-year survival, is a promising therapy that warrants further study.
STUDY... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2524183</comments>
            <pubDate>Sat, 27 Jun 2009 10:29:53 +0100</pubDate>
            <guid isPermaLink="false">2524183</guid>        </item>
        <item>
            <title>Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy</title>
            <link>http://www.medworm.com/index.php?rid=2486093&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FProspective_Minimal_Residual_Disease_Monitoring_to_Predict_Relapse_of_Acute_Promyelocytic_Leukemia_and_to_Direct_Pre_Emptive_Arsenic_Trioxide_Therapy.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
Large prospective study shows significantly improved relapse rates using assessment of MRD by real-time qualitative PCR combined with... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2486093</comments>
            <pubDate>Thu, 25 Jun 2009 07:20:08 +0100</pubDate>
            <guid isPermaLink="false">2486093</guid>        </item>
        <item>
            <title>Margin Clearance and Outcome After Pancreatectomy</title>
            <link>http://www.medworm.com/index.php?rid=2486092&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FMargin_Clearance_and_Outcome_in_Resected_Pancreatic_Cancer.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
Patients with margin clearance (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2486092</comments>
            <pubDate>Thu, 25 Jun 2009 07:20:08 +0100</pubDate>
            <guid isPermaLink="false">2486092</guid>        </item>
        <item>
            <title>Relapse-Related Molecular Signature in Lung Adenocarcinomas Identifies Patients With Dismal Prognosis</title>
            <link>http://www.medworm.com/index.php?rid=2486091&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FRelapse_Related_Molecular_Signature_in_Lung_Adenocarcinomas_Identifies_Patients_With_Dismal_Prognosis.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
A validated molecular signature effectively identified patients at high risk for relapse and death, even in stage IA lung adenocarcinoma.
STUDY... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2486091</comments>
            <pubDate>Thu, 25 Jun 2009 07:20:08 +0100</pubDate>
            <guid isPermaLink="false">2486091</guid>        </item>
        <item>
            <title>Connective Tissue-Activating Peptide III: A Novel Blood Biomarker for Early Lung Cancer Detection</title>
            <link>http://www.medworm.com/index.php?rid=2486090&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FConnective_Tissue_Activating_Peptide_III_A_Novel_Blood_Biomarker_for_Early_Lung_Cancer_Detection.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
A multimodal risk prediction model combines the CTAP III/NAP-2 and haptoglobin biomarkers with clinical factors for early lung cancer... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2486090</comments>
            <pubDate>Thu, 25 Jun 2009 07:20:08 +0100</pubDate>
            <guid isPermaLink="false">2486090</guid>        </item>
        <item>
            <title>Duration of Androgen Suppression in the Treatment of Prostate Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2486089&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FDuration_of_Androgen_Suppression_in_the_Treatment_of_Prostate_Cancer.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
At 5 years, overall mortality and prostate cancer−specific mortality were higher with short-term vs long-term androgen suppression.
STUDY... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2486089</comments>
            <pubDate>Thu, 25 Jun 2009 07:20:08 +0100</pubDate>
            <guid isPermaLink="false">2486089</guid>        </item>
        <item>
            <title>The Effect of Modafinil on Cognitive Function in Breast Cancer Survivors</title>
            <link>http://www.medworm.com/index.php?rid=2486088&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FThe_Effect_of_Modafinil_on_Cognitive_Function_in_Breast_Cancer_Survivors.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
Modafinil in breast cancer patients following chemotherapy was shown to improve several aspects of cognitive function.
STUDY IN CONTEXT
Following... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2486088</comments>
            <pubDate>Thu, 25 Jun 2009 07:20:08 +0100</pubDate>
            <guid isPermaLink="false">2486088</guid>        </item>
        <item>
            <title>Diagnostic Accuracy of Computed Tomographic Colonography for the Detection of Advanced Neoplasia in Individuals at Increased Risk of Colorectal Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2486087&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FDiagnostic_Accuracy_of_Computed_Tomographic_Colonography_for_the_Detection_of_Advanced_Neoplasia_in_Individuals_at_Increased_Risk_of_Colorectal_Cancer.html</link>
            <description>Supplementary editorial provided by OncologySTAT
TAKE-HOME MESSAGE
CT colonoscopy may provide a safe, effective, and noninvasive vehicle for screening in patients at increased risk for developing CRC.
STUDY... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2486087</comments>
            <pubDate>Thu, 25 Jun 2009 07:20:08 +0100</pubDate>
            <guid isPermaLink="false">2486087</guid>        </item>
        <item>
            <title>Outcome of Primary Tumor in Patients With Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery as Initial Treatment</title>
            <link>http://www.medworm.com/index.php?rid=2478956&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FOutcome_of_Primary_Tumor_in_Patients_With_Synchronous_Stage_IV_Colorectal_Cancer_Receiving_Combination_Chemotherapy_Without_Surgery_as_Initial_Treatment.html</link>
            <description>In patients who present with asymptomatic metastatic colorectal cancer with unresectable metastases, the benefit of primary tumor resection for the prevention of tumor-related complications is unclear.... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2478956</comments>
            <pubDate>Tue, 16 Jun 2009 23:00:29 +0100</pubDate>
            <guid isPermaLink="false">2478956</guid>        </item>
        <item>
            <title>Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents With Recurrent and Refractory Hodgkin's Lymphoma: An Analysis of the European Group for Blood and Marrow Transplantation</title>
            <link>http://www.medworm.com/index.php?rid=2478955&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FAllogeneic_Hematopoietic_Stem_Cell_Transplantation_in_Children_and_Adolescents_With_Recurrent_and_Refractory_Hodgkins_Lymphoma.html</link>
            <description>Ninety-one children and adolescents 18 years who received allogeneic hematopoietic stem cell transplantation (HSCT) for relapsed or refractory Hodgkin's lymphoma (HL) were analyzed. Fifty-one patients... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2478955</comments>
            <pubDate>Tue, 16 Jun 2009 23:00:29 +0100</pubDate>
            <guid isPermaLink="false">2478955</guid>        </item>
        <item>
            <title>Plerixafor and G-CSF Versus Placebo and G-CSF to Mobilize Hematopoietic Stem Cells for Autologous Stem Cell Transplantation in Patients With Multiple Myeloma</title>
            <link>http://www.medworm.com/index.php?rid=2478954&amp;cid=s_38624_6_f&amp;fid=38624&amp;url=http%3A%2F%2Fwww.oncologystat.com%3A80%2Fjournals%2Fjournal_scans%2FPlerixafor_and_G_CSF_Versus_Placebo_and_G_CSF_to_Mobilize_Hematopoietic_Stem_Cells_for_Autologous_Stem_Cell_Transplantation_in_Patients_With_Multiple_Myeloma.html</link>
            <description>This phase 3, multicenter, randomized (1:1), double-blind, placebo-controlled study evaluated the safety and efficacy of plerixafor with granulocyte colony-stimulating factor (G-CSF) in mobilizing hematopoietic... (Source: OncologySTAT Journal Scans)</description>
            <author>OncologySTAT Journal Scans</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2478954</comments>
            <pubDate>Tue, 16 Jun 2009 23:00:29 +0100</pubDate>
            <guid isPermaLink="false">2478954</guid>        </item>
    </channel>
</rss>

